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1. INTRODUCTION 
1.1 The male reproductive system 
The male reproductive system consists of a number of sex organs: the testicles, 
the excurrent duct system (comprising the epididymides and vasa deferentia), 
accessory glands (including the seminal vesicle and prostate gland), as well as the 
penis. The penis and scrotum which contains the testes and epididymides are located 
externally. The testes are positioned inside the scrotum and fulfill two major functions: 
generating male the gamete--sperm and secreting male sexual hormones such as 
testosterone. The sperm are transported from the rete testis via testicular efferent ducts 
to the epididymis which is cupping the backside of each testis. In human, multiple 
efferent ducts form the caput epididymis and eventually unite into one single tightly 
coiled epididymal tubule [1]. In rodents, several ductules merge into a single duct 
prior to entering the epididymis, which displays three grossly distinguishable regions: 
caput, corpus and cauda epididymides. The spermatozoa shed from the testis are still 
immature and without fertilization capability. Sperm maturation takes place in the 
epididymis and this process is associated with morphological, physiological and 
biochemical changes in male gametes [1,2]. Mature sperm expelled by contractions 
from the epididymis are transported through the vas deferens which is a muscular tube 
connecting the epididymis and seminal vesicle. Within seminal vesicles, fructose and 
the majority of ejaculatory fluid is produced to provide sperm with energy aiding their 
motility [1]. Additional components of semen are secreted from the prostate which is 
also required for the nourishment of sperm.  
1.2 Structure and functions of the testis  
The testes are enclosed in a fibrous white organ capsule of dense connective 
tissue (the tunica albuginea). The tunica albuginea penetrates testicular parenchyma 
and continues on the posterior side of the testis as the mediastinum [3]. The 
parenchyma occupies up to 90% of testicular mass and is divided into a number of 
lobules by the loose areolar connective tissue (septa testis), which is the extension of 
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tunica albuginea inside testis [4]. Each lobule comprises a tubular compartment and 
an interstitial compartment which corresponds to two primary functions of testis: 
androgen secretion and spermatogenesis.  
1.2.1 Tubular compartment and spermatogenesis 
Spermatogenesis is the process by which testicular stem cells develop into 
spermatozoa, including four successive phase: (1) mitosis of spermatogonia (2) 
meiosis of spermatocytes (3) spermiogenesis and (4) spermiation [1]. It is facilitated 
within seminiferous tubules that contain Sertoli cells (SC), developing germ cells in 
the stratified epithelium and peritubular cells (PTC) at the basal compartment. Type A 
spermatogonia have two subtypes--dark (Ad) or pale (Ap) which are positioned on the 
basement membrane of seminiferous tubules. Ad spermatogonia represent testicular 
stem cells without proliferation activity [5]. They rarely divide only when the overall 
population of spermatogonia is dramatically reduced [6]. In contrast, Ap 
spermatogonia are able to divide and proliferate by mitosis to produce type B 
spermatogonia. Type B spermatogonia are able to mitotically divide into primary 
spermatocytes, which are characterized by prominent round nuclei with a coarse 
chromatin pattern. Following a long stage of development, primary spermatocytes 
undergo their first meiotic division to become secondary spermatocytes. These cells 
proceed through the secondary stage quickly and undergo second meiosis for 
engendering spermatids. The spermatid is a haploid male gamete containing only half 
the genetic material inherited from the primary spermatocyte. When formed, early 
spermatids are round shape, and must go through further maturation to develop into 
elongated spermatids which eventually differentiate into sperm. This process known 
as spermiogenesis comprises nuclear condensation, acrosome formation, flagellum 
formation and cytoplasm reduction [1]. The final phase of the spermatogenic process 
results in the release of sperm from the germinal epithelium into the lumen, which is 
affected by hormonal alteration, temperature variation and toxins [1].  
The process of spermatogenesis is accomplished in close contact with SC, which 
support and nourish all stages of developing sperm cells. These nurse cells locate on 
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the basement membrane of seminiferous tubules and extend to the lumen with 
cytoplasm, surrounding different types of germ cells, and they also act as phagocytes 
consuming the unneeded portions of germ cells (residual bodies) and unreleased 
sperm [7]. In addition to the supportive and nurturing function, SC also play an 
important role in maintaining the special immune environment within the testis [8]. 
The occluding junctional complexes, also known as tight junctions, connect two 
adjacent Sertoli cells and give rise to the blood-testis barrier (BTB). BTB separates 
the epithelium into two compartments: the basal compartment in which only 
spermatogonia and very early primary (leptotene and zygotene) spermatocytes are 
found, and the adluminal compartment which contains the neo-antigens of more 
advanced meiotic and haploid germs cells. The tight junctions are able to dynamically 
dissolve and reassemble for the apical progression of spermatogonia [9]. Thus, 
spermatogonia can pass through the barrier and differentiate into haploid cells 
exhibiting new surface antigenic properties at the adluminal compartment. By 
controlling the exchange of nutrients, hormones and other essential materials, SC 
protect the isolated spermatocytes, spermatids and spermatozoa from the potentially 
detrimental factors. Furthermore, SC can secrete numerous substances such as inhibin, 
activins, transforming growth factor (TGF), androgen binding protein (ABP) and 
anti-Müllerian hormone (AMH) which are essential for spermatogenesis regulation 
[10-12]. Moreover, the expression of Toll-like receptors (TLRs), and secretion of 
cytokines including interferon (IFN)-alpha, IFN-beta, IFN-gamma, interleukin (IL)-1, 
IL-6 and tumor necrosis factor (TNF)-α have been identified in SC [13,14], which is 
indicative of SC playing a role in the innate immune system in the testis [15]. It has 
been suggested that SC may be derived from mesonephros [16]. Therefore, SC cannot 
divide once fully differentiated in adulthood and the number of them remains constant 
even after damage to the seminiferous epithelium has occurred [17].   
The seminiferous tubules are surrounded by a lamina propria which consists of a 
basal membrane, a collagen layer and PTC. The PTC have been found in all 
mammalian species, but the organization of cellular layers varies by species [18]. In 
humans and some mammals, the seminiferous tubules are covered by several layers of 
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PTC. This is in contrast to laboratory rodents such as rats and mice where there is 
only one cellular layer in the lamina propria of tubules [19]. Apart from providing 
structural integrity, PTC are able to contract and take part in the transport of sperm 
and testicular fluid towards the rete testis [20,21]. Furthermore, previous studies have 
demonstrated that PTC express androgen receptors and secrete numerous of 
substances including extracellular matrix components, growth factors and cytokines 
[22-24]. This suggests that PTC may contribute to the regulation of spermatogenesis 
and host immune responses in the testis [18].  
1.2.2 Interstitial compartment 
Between the seminiferous tubules lies the interstitium, which contains various 
cell types including Leydig cells (LC), testicular macrophages (TM), dendritic cells 
(DC) and fibroblasts [1]. In human, the interstitial compartment of the testis 
comprises about 12-15% of the total testicular volume, whereas it represents only 
about 2.6% in experimental animals [1]. LC are considered the most important cells in 
this compartment, as they produce and secrete testosterone into neighboring tissues 
and blood. Secreted testosterone is able to influence testis functions and also affects 
other tissue types [25]. Not only LC but also immune cells including TM, DC, T cells 
and natural killer cells are present within the interstitium. Together with SC and PTC, 
these interstitial cells contribute to the maintenance of a special immune milieu in the 
testis [26].  
1.3 Testicular immunology   
1.3.1 Immune privileged status of the testis 
It has been demonstrated in different laboratory rodents that the transplantations 
of sperm from the testis to other parts of body could cause autoimmune response, 
although they are tolerated in the testis [27-29]. The fact that the post-meiotic and 
haploid male gametes firstly appear at puberty after the establishment of body 
immune tolerance may explain why the germ cells are regarded as foreign and able to 
cause immune reaction outside the testis [30]. Therefore, certain mechanisms must 
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exist in the testis for gametes protection and autoimmune attack prevention. So far, 
experiments have uncovered a few unique features about testicular immunology. Most 
importantly, the testis has been proved as an immunologically privileged organ, which 
possesses a reduced ability to mount the rejection and inflammatory response [30,31]. 
Although the BTB provides a shelter for developing germ cells, it is believed that the 
barrier alone cannot account for the whole immunologically privileged situation in the 
testis [32]. However, the mechanisms responsible for the immunoprotective property 
of the testis are just partially understood. Recently, some studies have suggested that 
in addition to the BTB, a number of biological processes likely contribute to 
maintaining the special immune microenvironment in the testis. For example, in 
response to the challenge of bacteria component, the activated TM produce relatively 
lower levels of proinflammatory cytokines compared to peritoneal macrophages [33]. 
Moreover, co-transplantation experiments confirmed that the mature SC exert 
immunoprotective functions during allogeneic and xenogeneic transplantation [34,35]. 
It appears that SC are able to inhibit the proliferation and modify the differentiation of 
T cells by producing a series of immunomodulatory factors and Fas ligand [36,37]. 
Furthermore, the suppression of autoreactive T lymphocytes can also be mediated by 
regulatory T cell populations as well as the lacking of antigen-independent 
co-stimulatory molecules in the testis [29]. Finally, there are some locally produced 
factors such as testosterone and TGF-ß in the interstitial fluid of the testis which 
potentially inhibit the immune activation and result in weaken innate and adaptive 
immune response [38-40]. Instead of single mechanism acting alone, accumulating 
evidences suggested that both testicular somatic and immune cells synergistically 
create a tolerogenic milieu in the testis. Even though the testis is considered an 
immunologically privileged site, the immunocompetent cells such as leukocytes in the 
testis are still able to mount pro-inflammatory responses to combat infection [26].  
1.3.2 Immunocompetent cells of the testis 
Testicular leukocytes are found in the testicular interstitium, which comprise 
different types of populations. The primary function of these leukocytes is to mediate 
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immune response together; additionally they also play a role in the homeostatic 
regulation in the testis. 
In rodent testis, TM are the largest population of immune cells. They originate 
from the circulating monocytes which migrate to the testis and differentiate into 
resident macrophage [41]. The resident TM do not move back to circulation, on which 
the integrin can be uniquely recognized with the marker ED2 in the rat (specific for 
CD 163). The macrophage marker ED1 (specific for a lysosomal molecule CD68) can 
help to distinguish another subset of “newly arrived” macrophages, which is also 
present within the testis [42]. The immunosuppressive role of the resident TM is 
supported by previous studies, whereas the ED1 (+) macrophages demonstrate distinct 
phenotypes associated to the statues of the testis [43]. These newly arrived TM 
isolated from the normal rat testis showed even relatively poor responsiveness to LPS 
[44]. However, upon inflammatory stimuli the ED1 (+) TM, of which the majority 
may be infiltrating monocytes, are regarded as pro-inflammatory macrophage and 
responsible to sustain inflammatory responses for at least a limited period of time 
inside the testis [45]. In response to infectious insults, TM can get activated and be 
able to eliminate the invading micro-organism, but to a less extent than other types of 
macrophages like peritoneal macrophages [15,46]. Aside from the role of 
immunological regulator in the testis, TM also contribute to the maintenance of 
normal testicular functions and modulation of Leydig cell steroidogenesis [47-50]. 
These evidences indicate that immune-endocrine interactions play a role in regulating 
the functions of the testis under normal and pathological conditions. 
DC is another kind of antigen-presenting cell present in the testis, although with a 
relative small population. Some studies have shown that dendritic cells are implicated 
in the development of experimental autoimmune orchitis (EAO) [51,52], as they 
likely contribute to inflammation within the testis [53]. T lymphocytes which form an 
essential part in the cell-mediated immune response are also present and constitute 
about 10~20% of immune cells in the testis of rodents and humans under normal 
condition [54]. Also the natural killer T cell, the special type of lymphocytes which 
bridges the adaptive immune system with the innate one, is found in the testes of 
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rodents and human [55]. In the rat testis, the numbers of both effector T cells and 
regulatory T cells increase dramatically whilst autoimmune orchitis occurs [56]. 
However, there is remarkable evidence showing the existing T cells inhibition 
mechanisms in the testis. Some regulatory factors in the testis such as TGF-ß, 
prostaglandin and activin all exhibit lymphocyte-inhibiting activity [55].  As the 
most abundant type of leukocyte in blood stream, neutrophils normally are not present 
in testis, but they can be recruited from circulation to the sites of injury in response to 
pathogen invasion, inflammatory stimulus or tissue damage. For example, upon 
intraperitoneal injection with LPS, testicular torsion or the treatment with human 
chorionic gonadotropin (hCG) which increase the permeability of blood vessel, 
neutrophils could enter the testis in rat [45,57,58]. Once be activated, neutrophils 
together with migrating monocytes-macrophage and lymphocytes may not be affected 
by the immunosuppressive environment in the testis, thus the inflammatory reaction 
brought by these cells should be tightly regulated since inflammation-induced damage 
can potentially disrupt the testicular functions and lead to infertility [59].   
Aside from testicular immune cells, accumulating studies have suggested that 
testicular somatic cells including SC, LC as well as PTC are also immunocompetent 
cells in this organ. These somatic cells, particularly SC and LC, are able to produce 
several pro-inflammatory mediators, including IL-1, IL-6, MIF, IFN, and iNOS 
[60,61]. However, the crosstalk between testicular somatic cells and immune cells is 
largely unclear, further studies may help to gain a deeper insight into the exact role of 
testicular cells in maintaining testicular homeostasis. 
1.3.3 Innate immunity of the testis  
Toll-like receptors (TLRs) are a group of membrane spanning proteins which play 
a pivotal role in innate immunity. Recent studies have confirmed the expression of 
TLRs 1-11 in rat testicular macrophage, and TLRs 2-5 are found in rat SC, PTC and 
LC [15]. These TLRs expressed in mouse SC can be activated by their specific 
ligands and induce the increasing expression of pro-inflammatory cytokines in the 
testis [62,63]. Increasing data demonstrate that a series of cytokines play a key role in 
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the immunological homeostasis of the testis [64]. Some of them are also secreted 
within the testis under physiological conditions, such as IL-1α, IL-6 and TNF-α 
[65-68], acting as modulators in spermatogenesis, blood-testis barrier and 
steroidogenesis [69-76]. However, the upregulation of cytokine expression during 
infection and inflammation or trauma within the testis can contribute to fertility 
impairment and testicular dysfunction, either via directly inducing germ cell apoptosis 
or altering somatic cells functions and disturbing testicular microenvironment. 
Additionally, antimicrobial peptides such as defensins are also produced by various 
cell types in human and rodent testis. It is assumed that these peptides may play an 
important role in innate defence against invading pathogens in the testis [77]. 
1.4 Male infertility and genital tract infections/inflammation 
Infertility can be defined as the inability to conceive after one year of regular 
sexual intercourse without the use of contraception [78]. Approximately 15% of 
couples cannot conceive within one year [79]. The underlying etiological factors can 
be the abnormalities or pathological situations affecting one or both members of an 
infertile couple. Various factors contributing to infertility from the male side are found 
in up to 50% unintended childlessness families [78]. Male infertility is usually 
associated with testicular dysfunction as a result of various abnormalities or 
disruptions. Recent studies on human testicular biopsies samples observed a 
pathology-associated increase in transcript levels corresponding to inflammatory 
activity and tissue remodeling in this organ [80,81]. These molecular changes 
included positive regulation of NF-ĸB cascade, MAPK pathways, as well as some 
other pathways implicated in inflammation, allergy and autoimmunity. At present, 
infections and inflammation of urogenital tracts, including the acute and chronic 
forms, are widely accepted as an important aetiological factor which accounts for 
about 10~15% of cases with male infertility [79]. The male reproductive tract can 
become a route of pathogen invasion via the urethra. Therefore, bacterial infections in 
male genital tract mainly originate from ascending urinary tract infections (UTIs) as 
well as sexually transmitted infections. Although male UTIs are not as frequent as in 
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females, once the infection occurs it may spread and affect different parts of the male 
reproductive tract incorporating the epididymis and testis [1]. UTIs exert detrimental 
influence on spermatozoa during development, maturation and transport. Compared to 
urethritis and prostatitis, infection or inflammation of the epididymis and testis are 
more likely to cause impairment of male reproductive function, as spermatozoa or 
germ cells may be directly exposed to pathogens and inflammatory products 
[59,82-84]. Critically, antibiotic treatment which efficiently eliminates bacterial 
infection within the epididymis or testis does not reverse anatomical or functional 
damage resulting from infection or inflammation [85]. To date the role of bacterial 
infection and inflammation within the testis and epididymis contributing to male 
infertility has yet to be elucidated. 
1.4.1 Pathogens involved in orchitis  
Previous studies have demonstrated a correlation between bacterial infection and 
male infertility. Orchitis is an inflammatory condition of the testes secondary to 
infections. It results in leukocytes infiltration outside the seminiferous tubules, which 
can be observed inside the tubules in more severe cases as well [59]. With the 
exception of specific viral infections, orchitis is usually in combination with acute 
epididymitis due to retrograde infection, known as epididymo-orchitis [86]. Among 
the sexually active men between 14~35 year of age, sexually transmitted pathogens 
including Chlamydia trachomatis and Neisseria gonorrhoeae are among the most 
common pathogens related to epididymo-orchitis [86-88]. Escherichia coli (E. coli) 
and other Enterobacteriaceae belonging to the genera Klebsiella, Salmonella and 
Proteus are the primary pathogens implicated in non-sexually transmitted 
epididymo-orchitis [59,89]. Uropathogenic E. coli (UPEC) account for the vast 
majority of urinary tract infections and thus are assumed to be the likely substrain 
responsible for the E. coli elicited epididymo-orchitis [90-92]. Apart from those 
bacteria mentioned above, mumps virus is the most common pathogen which can 
cause isolated orchitis in pre-pubertal males [93,94]. Others pathogens which are 
found in male reproductive tract and related with subfertility include Herpesvirus 
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(HSV), Human papilloma viruses (HPV), Coxsackie A virus, Mycobacterium 
tuberculosis as well as Human immunodeficiency viruses (HIV) [90,95,96].  
1.4.2 Uropathogenic E. Coli  
As a primary candidate in UTIs, E. coli are commonly isolated from semen or the 
prostatic fluid of infertile men and the patients with prostatitis or epididymitis 
[91,92,97]. Despite most of the E. coli strains are harmless, some are able to persist in 
the urinary tract and initiate infections. Since the specific pathotype of E. coli has yet 
to be determined for UTIs, “Uropathogenic E. coli” (UPEC) becomes a designation in 
common usage for all E. coli strains eliciting UTIs [98]. UPEC are responsible for 
approximately 70~90% of cases with community acquired urinary tract infections and 
most likely account for E. coli induced epididymo-orchitis [99]. Numbers of virulence 
factors expressed by UPEC enable the pathogen to adhere to the uro-epithelial cells 
and spread from low urinary tract up to bladder, kidneys, as well as genital tract in 
males, resulting in ascending infections. In general, two main types of virulence 
factors in UPEC were described, one is produced on the bacterial surface and the 
other one is synthesized inside the bacteria and subsequently exported to the site of 
infection [100]. The surface virulence factors include different types of pili (type I, P, 
S, and F1C) which facilitate the pathogen adhesion to mucosal and endothelial cells, 
the capsular material protecting bacteria from host immune attack, as well as the 
endotoxin Lipopolysaccharide (LPS) exhibiting endotoxic effects and evoking 
inflammatory response [101-103]. On the other hand, the exported virulence factors 
of UPEC mainly exert the cytotoxic and anti-host cells activities, including toxins 
(such as α-hemolysin [HlyA], cytotoxic necrotizing factor 1 [CNF1], cytolysin A, 
autotransporter toxin), iron acquisition systems and others [104-106].  
The virulence factors are usually encoded by genetic elements termed 
pathogenicity islands (PAIs) [107,108]. Generated by horizontal gene transfer which 
contributes to the microbial evolution, PAIs comprise large DNA regions (10~200 kbp) 
with flexible sequences associating with tRNA genes [100]. UPEC strains usually 
possess several PAIs, which largely determine the virulence traits of bacteria 
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[100,109]. Individual deletion of any single PAI could not affect the survival curves in 
murine urosepsis model, whereas simultaneously loss of two PAIs significantly 
attenuated the virulence [110]. Thus far, the genome of a representative member of 
UPEC, strain CFT073 (O6:K2:H1), has been entirely sequenced and published 
[GenBank: AE014275. 1] [111], with a recent reannotation in 2009 [112]. These 
publications provide a comprehensive understanding on the genetic basis of 
uropathogenic potential of this pathogen.  
Like other microbial pathogens, UPEC can also evolve various strategies to evade 
host defense response, including invasion/penetration inside host cells, elimination of 
key immunocompetent cells, and suppression of host immune defence [15]. For 
example, the pore-forming toxin HlyA, which is one of the most important virulence 
factors of UPEC, can not only lysis erythrocytes but also target other cells types 
including leukocytes and uro-endothelial cells [113]. Recent observation further 
confirmed that hemolytic activity is possessed in more than 50% of E. coli samples 
isolated from patients with epididymitis (Clinic of Urology, Giessen, personal 
communication). Intriguingly, recent studies suggested that HlyA also contributes to 
the UPEC induced immunosuppression in peritoneal macrophages and testicular 
somatic cells (Sudhanshu Bhushan, et al. data is not published). Better understanding 
of host response against pathogens in epididymo-orchitis can shed more light on the 
mechanisms of UTIs caused male infertility.   
1.5 Host response in UTIs 
Upon the UTIs the immune surveillance molecules present in urinary tract (such 
as TLRs) recognize the invading pathogens by special pathogen associated molecular 
patterns (PAMPs) [114]. In response to infections, host defence initially mobilizes 
innate and adaptive immune systems in various ways to clear infections, which is 
carried out by recruiting and activating immune cells, triggering various inflammatory 
pathways, secreting antimicrobial peptides, synthesizing specific antibodies in serum 
and urine and resisting bacterial invasion [115-117]. Once the infections persist and 
pathogens invasion occurs, a variety of cell death modes are actively triggered to 
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eliminate the infected cells and expose intracellular pathogens to the immune system 
[118]. These inherently regulated or intracellular program mediated cell death modes 
are termed “programmed cell death” [119]. By far three major programmed cell death 
mechanisms are characterized, named apoptosis, programmed necrosis, and 
pyroptosis [120]. The biochemical basis and features of these three types of cell death 
are described as follows.   
1.6 Programmed cell death 
1.6.1 Apoptosis 
Apoptosis, a term stemming from a Greek word with the meaning of “dropping 
off” or “falling off” of petals or leaves from plants, was first reintroduced to describe 
a form of controlled cell deletion in 1972 by Kerr and his colleagues [121]. To date, 
apoptosis has been well-studied and characterized as a special kind of cell suicide 
phenomenon. Classically, a cell undergoing apoptosis shows a series of characteristic 
morphologic features in sequence: cell shrinkage and plasma membrane blebbing 
(without losing membrane integrity), chromatin condensation into compact patches 
(pyknosis), DNA fragmentation and nucleus breakage (karyorrhexis) and 
membrane-enclosed cell fragments formation (apoptotic bodies) [122,123].  
1.6.1.1 Process of apoptosis  
Apoptosis is not only viewed as an important physiological event during 
embryogenesis, nervous system development and homeostasis maintenance of adult 
organisms, but also implicated in a variety of stress induced injury. Certain stress 
stimuli (i.e. hypoxia, radiation, microbial infection, heat shock, intracellular calcium 
influx and nutrient or growth factors deprivation) can trigger the transduction of 
apoptotic signals, which subsequently interact with regulatory proteins and initiate 
different apoptosis pathways [124,125]. Generally apoptosis or apoptosis-like cell 
demise can be categorized into two distinct mechanisms according to the involvement 
of a family of cysteine-dependent aspartate-directed proteases (caspases): entitled 
caspase-dependent (classical apoptosis) and -independent pathway [124,126].   
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1.6.1.2 Caspase-dependent pathway 
So far, at least 14 caspases have been identified in mammals of which 11 were 
confirmed in human [127-129]. Apart from the inflammatory caspases including 
caspase-1, -4, -5, -11~-13, the rest of the caspases members which belong to the 
Caenorhabditis elegans cell death gene-3 (CED-3) subfamily are apoptotic related 
proteases comprising two subgroups: initiator and executor caspases [127,130]. The 
former subgroup comprises caspase-2, -8, -9, and -10, and the latter one includes 
caspase-3, -6 and -7. These caspases trigger apoptotic machinery via two distinct 
ways: the intrinsic and extrinsic apoptotic signaling pathways (Figure 1). The 
mitochondrial regulation is the core process of intrinsic signaling pathways, in which 
Bcl-2 family members play a central role [131]. These proteins share at least one of 
the four homological regions named the Bcl-2 homology (BH) domains (BH1~4) and 
they are able to form hetero- or homodimers [132]. In response to a certain apoptotic 
stimuli such as chemotherapeutics or UV irradiation, a group of pro-apoptotic Bcl-2 
family members (i.e. Bax, Bak, Bid and Bim) can either permeabilize or form pores 
on the mitochondrial membrane and thereby induce the release of mitochondrial 
apoptogenic factors like cytochrome c, SMAC/Diablo (Second Mitochondria-derived 
Activator of Caspases/Direct IAP Binding Protein with Low PI) and HtrA2/Omi [133]. 
Following the formation of mitochondrial outer membrane permeabilization pore 
(MAC), cytochrome c is leaking out and recruited by the central scaffold protein 
apoptotic protease activation factor-1 (Apaf-1) together with ATP and pro-caspase-9 
in cytosol. Together they form the apoptosome followed by the activation of caspase-9 
within this complex, which in turn proteolytically activates the executor caspases 
[134,135]. The spilled out SMAC/Diablo and HtrA2/Omi exert their pro-apoptotic 
function by deactivating IAPs (inhibitor of apoptosis proteins), which exerts 
suppression of caspases activity [136,137]. On the other hand, mitochondrial 
permeability is also regulated by anti-apoptotic Bcl-2 family members including Bcl-2, 
Bcl-w and Bcl-xL, which can reduce Bax activation by binding to Bid or directly 
inhibit the pore-forming function of Bax and Bak by heterodimerization [133]. 
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Therefore the ratio of Bcl-2/Bax indicates the balance that decides a given cell will 
either execute or ignore an apoptotic stimulus [138]. Beside the mitochondrial 
regulation, apoptotic signals can be transducted via the extrinsic signaling pathway 
that is initiated by the binding of death receptor ligands (i.e. TNF-a, Fas ligand) to 
their respective transmembrane receptors [139,140]. The interaction between these 
ligands and death receptors leads to the formation of the death-inducing signaling 
complex (DISC) containing Fas-associated death domain protein (FADD), caspase-8 
and -10 [141]. The initiator caspases are activated in DISC and they can either cleave 
downstream executor caspases or truncate and activate another Bcl-2 homology 
domain 3 (BH3)-only protein -- Bid, which in turn leads to the insertion of Bax onto 
the mitochondrial membrane, acting as a link between the intrinsic and extrinsic 
pathways [142]. 
Generally the caspase-dependent pathway is activated in two-step cascade. Firstly 
the initiator caspases are recruited in two distinct protein complexes (the apoptosome 
complex and DISC) which are respectively implicated in the intrinsic and extrinsic 
apoptotic signaling pathways. The initiator caspases get autoactivated in these 
complexes and thereby trigger the proteolytic maturation of executor caspases. Then 
the activated executor caspases amplify the lethal signal by cleaving their protein 
substrates (i.e. poly-ADP ribose polymerase [PARP], inhibitor of caspase activated 
DNase [ICAD], nuclear lamins) and initiate irreversible disassembly of cell into 
apoptotic bodies [143].  
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Figure 1 The intrinsic and extrinsic apoptotic signaling pathways (Lamkanfi, 
M. and V. M. Dixit, 2010). 
1.6.1.3 Caspase-independent pathway  
Apoptosis-like cell death can also be carried out by mechanisms other than the 
traditional caspases-mediated cleavage cascade. There are several death effectors that 
also can trigger cell death independently without participation of caspases [144]. 
Apoptosis inducing factor (AIF) is one of the best characterized proteins implicated in 
caspase-independent pathway, although the exact mechanism is still not fully 
understood. AIF is a flavoprotein which is secluded behind the outer membrane of 
mitochondria under normal circumstances [145]. This flavoprotein exerts vital 
function in mitochondrial respiration and displays NADH oxidoreductase and 
peroxide scavenging activities [146]. Apart from its vital role, AIF can also act as a 
cell death effector. Upon cell death signaling, AIF is released from the permeabilized 
mitochondria and translocates via cytosol to nucleus. Once AIF is move into the 
cytosol, it can facilitate further release of this protein from mitochondria and therefore 
it triggers a positive feedback amplification loop [147]. In nucleus AIF binds to DNA 
and induce peripheral chromatin condensation (chromatinolysis) and high molecular 
weight (~50 kbp) DNA fragmentation in a caspases-independent manner [122,145]. 
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Notably, in particular conditions AIF can also trigger necrosis-like programmed cell 
death, which is characterized with cellular membranes rupture and pro-inflammatory 
consequence [148,149]. It has been shown that the AIF mediated apoptosis-like or 
necrosis-like cell demise is largely dependent upon the cell types and specific lethal 
stimuli [150].  
1.6.1.4 Outcome of apoptosis  
During the procedure of apoptosis, dying cells are marked by the exposure of 
some phagocytic molecules like phosphatidylserine (PS) on the extracellular surface 
[151]. The neighboring phagocytic cells such as macrophages recognize the 
phagocytic molecules labeled apoptotic cells and remove them by phagocytosis. The 
engulfment and ingestion of apoptotic cells debris actively prevents leakage of 
cytoplasmic content. A great body of evidence has shown that apoptosis does not elicit 
inflammatory response, it may even suppress the release of pro-inflammatory 
cytokines and inhibit maturation of dendritic cells in most of cases [152,153]. 
Therefore, for a long time it is believed that apoptosis is a noninflammatory form of 
cell death, which distinguishes itself from other cell death modes like necrosis. 
However, the apoptosis related immune unresponsiveness can be overridden by 
unclear mechanism, as accumulating studies demonstrated that apoptosis can also 
provoke inflammatory response by stimulating neutrophil chemoattractant release, 
inducing monocytes infiltration, activating antigen presentation by dendritic cells 
[154-156]. Nevertheless, it is increasingly recognized that apoptosis plays an essential 
role in immune regulation more than just elimination of unwanted cells [157]. 
1.6.2 Programmed necrosis 
The term of “necrosis” originates from the Greek word “nekros” which means 
“death or the stage of dying” [158]. Necrosis is an important mode of cell death under 
pathological conditions, which distinguishes itself from apoptosis by many visible 
morphological and biochemical features as well as by the pathological consequence 
[159]. Necrotic cell death is usually triggered by a variety of extreme 
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non-physiological stress such as hypoxia, ischemia, microbial infection and toxins. 
Morphologically necrosis is characterized by electron-lucent cytoplasm, swelling of 
cellular organelles and loss of plasma membrane integrity followed with total cell 
lysis [158,160]. In contrast to apoptosis, the DNA of necrotic cells is randomly 
degraded during cell death, giving rise to a smear after agarose gel electrophoresis. 
Unlike the formation of membrane bounded apoptotic bodies observed during 
apoptosis, plasma membrane integrity is rapidly compromised in necrotic cells and 
results in spilling of intracellular contents into extracellular space [161]. A cytokine 
mediator high-mobility group protein B1 (HMGB1) is one of the “danger signals” 
sent by necrotic cells [162,163]. In physiological conditions, HMGB1 stabilizes 
nucleosome formation and may regulate transcription as an architectural 
chromatin-binding factor in nucleus [164]. Upon immune stimulus, HMGB1 can be 
secreted by the activated monocytes and macrophages [162,165], and also can be 
passively released from necrotic and damaged cells [166]. This chromatin protein has 
recently identified as a marker of necrosis as it retains in the nuclei of healthy or 
apoptotic cells but can be passively released into cytoplasm and extracellular space at 
a late stage of necrosis [167,168]. Therefore, necrosis inevitably affects neighboring 
cells, usually provoking significant inflammatory response and causing tissue injury 
[169].  
Necrotic cell death is prevalent in a various acute pathologies such as infection, 
myocardial infarction and injury [158,170]. Currently, inhibition of necrosis is not yet 
accepted as a therapeutic strategy because necrosis has long been considered as an 
accidental and uncontrollable cell death mode without involvement of any cell 
signaling pathway [171]. However, increasing studies suggest that necrosis also can 
be a well-orchestrated form of cell demise under certain conditions [148,172]. 
Although the underlying mechanism of programmed necrosis has not been completely 
unraveled, some possible signal transduction cascades and key mediators involved in 
necrotic cell death are clearly described. For example, TNFa treatment combining 
with caspases inhibitor is able to induce programmed necrosis in some cell types since 
apoptotic signaling cascade is failed to initiate [173]. Although the involved necrotic 
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pathway is not yet completely confined, the receptor interacting protein 
serine/threonine kinases (RIP) 1 and RIP3 are proved to play a pivotal role in the 
death receptor initiated programmed necrosis (Figure 2) [174,175]. The RIP1/RIP3 
signaling cascade is believed to trigger a series of downstream events that contribute 
to necrosis, such as calpain activation, lysosomal destabilization and mitochondrial 
dysfunction [176,177]. Mitochondrial dysfunction leads to excessive production of 
reactive oxygen species (ROS) and depletion of adenosine triphosphate (ATP). These 
key mediators are implicated in necrosis signaling cascade and determine the fate of 
cell death either by apoptosis or necrosis [178,179]. Furthermore, it is recently 
reported that AIF can also mediate alkylating DNA damage and consequently induce 
programmed necrosis [148]. These evidences suggest that programmed necrosis is the 
result of crosstalk between several cascades and cellular organelles [180]. Of note, the 
fact that the RIP1-specific inhibitors necrostatin-1, -3, -5 and RIP3 silencing are able 
to rescue cells from necrosis [171,173] sheds light on a better understanding of the 
regulation of this cell death mode and therefore facilitate the therapeutic intervention.   
  
 
Figure 2 RIP1/RIP3 signaling induces necrosis (Lamkanfi, M. and V. M. Dixit, 
2010). 
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1.6.3 Pyroptosis 
Apart from apoptosis and necrosis, there is an increasing awareness of another 
kind of cell death mode responding to infection/inflammation named pyroptosis. 
Pyrotosis is caspase-1 dependent programmed cell death which partially retains 
morphological and biological features from both apoptosis and necrosis [181]. Similar 
to necrosis, pyroptosis is also a sort of pro-inflammatory cell death which is 
characterized by plasma-membrane rupture and intracellular contents release. The 
DNA degradation accompanying with nuclear condensation also occurs in pyroptotic 
cells [182,183]. Unlike the apoptotic caspases, the central regulator in 
pyroptosis--caspase-1 is recruited and autoactivated in the inflammasomes complexes 
in response to a range of microbial infections (i.e. Shigella flexneri, Salmonella 
typhimurium, Pseudomonas aeruginosa) [184-187] and non-infectious stimuli such as 
myocardial infarction and cerebral ischemia [187,188]. Caspase-1 was initially called 
IL-1 β converting enzyme (ICE) because it is essential for maturation and secretion of 
pro-inflammatory cytokines IL-1 β and IL-18. However, it is found that pyroptosis is 
independent of the IL-1β and IL-18 [186] and the molecular mechanism of caspase-1 
inducing pyroptosis still remains unclear. 
1.7 Aim of study  
A growing body of evidence suggests that E.coli is one of the major pathogens 
implicated in bacterial epididymo-orchitis and potentially results in reduced fertility 
[90,189]. Currently, antibiotic treatment is the standardized therapy prescribed in 
acute bacterial epididymo-orchitis [85]. Unfortunately, successful elimination of 
invading pathogens with antibiotics administration doesn’t necessarily mean fertility 
can be fully restored [29,59]. Furthermore, the impairment of spermatogenesis 
remained unrecoverable even after the invading pathogen was obliterated by the host 
immune system within the testis [190]. Consequently, the treatment of 
epididymo-orchitis and secondary infertility is hindered by the limited understanding 
of the detrimental impacts following infections in these organs. Previous studies have 
described the deleterious effects of E. coli on ejaculated sperm and spermatogenesis 
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[191,192]. However, to date underlying mechanisms of spermatogenic disturbance 
caused by E.coli infection has yet to be elucidated. Moreover, the influence of E.coli 
infection on testicular somatic cells such as SC and PTC which contribute to 
maintenance of spermatogenesis and testicular homeostasis is still poorly understood. 
Given the immunological privileged status within the testis, it is critical to gain a 
comprehensive understanding of the interaction between E.coli and testicular cells. 
Therefore, investigation of damaging effects on spermatogenesis and responses of 
testicular cells upon UPEC infection, may allow us to gain deep insight into 
underlying mechanisms of epididymo-orchitis associated infertility, thus potentially 
providing valuable therapeutic tools. 
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2 MATERIALS AND METHODS 
2.1 Materials  
2.1.1 Chemicals 
Acetic acid Merck, Darmstadt 
Acrylamide 30% (w/v) Roth, Karlsruhe 
Agarose Invitrogen, Karlsruhe 
Bromophenol blue sodium salt Sigma-Aldrich, Steinheim 
Calcium chloride Merck, Darmstadt 
Dimethyl sulfoxide Merck, Darmstadt 
di-potassium hydrogen phosphate Merck, Darmstadt 
di-sodium hydrogen phosphate Merck, Darmstadt 
1,4-Dithiothreitol Roche, Mannheim 
Ethanol Sigma-Aldrich, Steinheim 
Ethidium bromide Roth, Karlsruhe 
Ethylene diaminetetraacetic acid disodium salt Merck, Darmstadt 
Formamide Merck, Darmstadt 
37% Formaldehyde solution Merck, Darmstadt 
Glycerol Merck, Darmstadt 
Glycine Sigma-Aldrich, Steinheim 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid Roth, Karlsruhe 
Igepal CA-630 (NP-40) Sigma-Aldrich, Steinheim 
Ketamine Inresa, Freiburg 
Lipopolysaccharide Sigma-Aldrich, Steinheim 
Magnesium chloride Merck, Darmstadt 
Magnesium sulfate Sigma-Aldrich, Steinheim 
β-Mercaptoethanol AppliChem, Darmstadt 
Methanol Sigma-Aldrich, Steinheim 
MTT Sigma-Aldrich, Steinheim 
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Non-fat dry milk Bio-Rad, Munich 
Orange G Merck, Darmstadt 
Paraformaldehyde Merck, Darmstadt 
Picric acid Merck, Darmstadt 
Phenylmethylsulfonyl fluoride Sigma-Aldrich, Steinheim 
Ponceau S Roth, Karlsruhe 
Potassium chloride Merck, Darmstadt 
Rotiphorese Gel 30 Roth, Karlsruhe 
Proteinase cocktail inhibitor Sigma-Aldrich, Steinheim 
Sodium acetate Roth, Karlsruhe 
Sodium azide Merck, Darmstadt 
Sodium chloride Sigma-Aldrich, Steinheim 
Sodium dodecyl sulfate Merck, Darmstadt 
N, N, N’, N’-Tetramethylethylenediamin Roth, Karlsruhe 
Tris (hydroxymethyl) aminomethane Roth, Karlsruhe 
Triton X-100 Sigma-Aldrich, Steinheim 
Tween-20 Roth, Karlsruhe 
Urea Merck, Darmstadt 
Xylazine Bayer, Leverkusen 
2.1.2 PCR reagents  
DNase I Invitrogen, Karlsruhe 
EDTA Invitrogen, Karlsruhe  
dNTP Promega, Mannheim 
MMLV RT Promega, Mannheim 
Oligo dT        Promega, Mannheim 
RNase A Carl Roth, Karlsruhe  
RNase inhibitor Promega, Mannheim 
Taq polymerase Promega, Mannheim 
SYBR green Bio-Rad GmbH, Munich 
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2.1.3 Enzymes for Sertoli cell and peritubular cell isolation  
Table 1 The list of enzymes used for Sertoli and peritubular cells isolation from 
rat testis. 
Enzyme Company Catalogue No. 
Collagenase A  Roche Diagnostics, Mannheim 103586 
DNase I Roche Diagnostics, Mannheim 104159 
Hyaluronidase Sigma-Aldrich, Steinheim  H3506-500MG 
Trypsin Roche Diagnostics, Mannheim 10109819001 
Trypsin inhibitor Roche Diagnostics, Mannheim 10109886001 
2.1.4 Antibodies 
Table 2 The information of primary antibodies used for Western blotting and 
immunofluorescence staining.  
Primary Antibody Manufacturer 
Catalogue  
No. 
Dilution 
(application)
Rabbit anti Caspase 1 Santa Cruz, California, USA SC514 1:250 (WB*)
Rabbit anti Caspase 3 Abcam, Cambridge, UK ab44976 1:500 (WB) 
Rabbit anti Caspase 6 
Cell Signaling Technology, 
Massachusetts, USA 
9762 1:1000 (WB)
Rabbit anti Caspase 8 
Cell Signaling Technology, 
Massachusetts, USA 
D35G2 1:1000 (WB)
Mouse anti human 
β-actin 
Sigma-Aldrich, Steinheim, 
Germany 
A5441 1:5000 (WB)
Mouse anti rat ED1 Serotec, Martinsried, 
Germany 
MCA341R 1:50 (IF**) 
Mouse anti rat ED2 
Serotec, Martinsried, 
Germany 
MCA342R 1:50 (IF) 
Goat anti human 
vimentin 
Sigma-Aldrich, Steinheim, 
Germany 
V4630 1:100 (IF) 
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Mouse anti human 
α-smooth muscle actin 
Sigma-Aldrich, Steinheim, 
Germany 
A2547 1:100 (IF) 
Rabbit anti E.coli  Abcam, Cambridge, UK ab68451 1:300 (IF) 
Rabbit anti HMGB1 Abcam, Cambridge, UK ab18256 1:500 (WB) 
1:200 (IF) 
Rabbit anti AIF *** - 1:100 (IF) 
Mouse anti IkBa Cell Signaling Technology, 
Massachusetts, USA 
4814 1:1000 (WB)
Mouse anti p65 
Santa Cruz, California, USA
SC8008 1:250 (WB) 
1:50 (IF) 
* WB: Western blotting 
** IF: immunofluorescence staining 
*** A gift from Dr. J. Landry (Laval University, Québec, Canada) 
 
Table 3 Secondary antibodies for Western blotting and immunofluorescence 
staining.  
 
Secondary antibody Manufacturer 
Catalogue   
No. 
Dilution
Donkey anti mouse IgG-Cy3 
Dianova, Hamburg, 
Germany 
715-165-151 1:1000 
Donkey anti rabbit IgG-Cy3 
Chemicon, Hampshire, 
UK 
AP182C 1:1000 
Donkey anti goat IgG-HRP 
Santa Cruz, California, 
USA 
SC-2020 1:1000 
Goat anti rabbit IgG -HRP ICN, Ohio, USA 55676 1:10,000
Sheep Anti mouse -HRP 
Sigma-Aldrich, 
Steinheim, Germany 
A5906 1:10,000
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2.1.5 Cell culture reagents 
Bovine serum albumin (endotoxin free) Invitrogen, Karlsruhe        
Dulbecco’s Minimal Essential Medium PAA Laboratories, Cölbe 
Dulbecco´s PBS (1X) w/o Ca2+ & Mg2+ PAA Laboratories, Cölbe 
Fetal calf serum PAA Laboratories, Cölbe 
L-Glutamine 200 mM (100X) PAA Laboratories, Cölbe 
Penicillin/Streptomycin (100X) PAA Laboratories, Cölbe 
RPMI 1640 medium PAA Laboratories, Cölbe 
DMEM (high glucose) medium PAA Laboratories, Cölbe  
Trypsin/EDTA PAA Laboratories, Cölbe 
2.1.6 Equipments 
Cell culture CO2 incubator Binder, Tullingen 
Confocal laser scanning microscope TCS SP2 Leica, Wetzlar 
Desktop centrifuge Biofuge Fresco Heraeus, Hanau 
Labofuge 400R Heraeus, Hanau 
Electronic balance SPB50 Ohaus, Giessen 
Zeiss EM 109 Zeiss, Oberkochen 
Flow cytometry BD FACScan, San Jose, USA 
Fluorescent microscope Axioplan 2 Imaging Carl Zeiss, Göttingen 
Gel Jet Imager 2000 documentation system Intas, Göttingen 
Heat block DB-2A Techne, Cambridge, UK 
Horizontal mini electrophoresis system PEQLAB, Erlangen 
Microwave oven Samsung, Schwalbach 
Microplate reader Berthold, Bad Wildbad 
Mini centrifuge Galaxy VWR International 
Mini-rocker shaker MR-1 PEQLAB, Erlangen 
Mixer Mill MM 300 Retsch, Haan 
MyiQTM2 Two-Color real-time PCR detection system Bio-Rad, Munich 
PCR thermo cycler Biozyme, Oldendor 
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Potter S homogenizer B. Braun, Melsungen 
Power supply units Consurs, Reiskirchen 
Pre-cast gel system Invitrogen, Karlsruhe 
SDS gel electrophoresis chambers Consurs, Reiskirchen 
Semi-dry-electroblotter PEQLAB, Erlangen 
Vertical electrophoresis system PEQLAB, Erlangen 
Ultrasonic homogenizer Bandelin Sonopuls Bandelin, Berlin 
UV visible spectrophotometer Ultrospec 2100 Pro  Biochrom, Cambridge, UK 
2.1.7 Miscellaneous 
Bio-Rad Protein Assay Bio-Rad, Munich 
DNA Ladder (100 bp) Promega, Mannheim 
DAPI Vector, Burlingame, USA 
Enhanced chemiluminescence (ECL) reagents Amersham, Freiburg 
Hybond ECL nitrocellulose membrane Amersham, Freiburg 
Protein size markers Invitrogen, Karlsruhe 
Sterile plastic ware for cell culture Sarstedt, Nümbrecht 
X-ray Hyperfilm Amersham, Freiburg 
2.1.8 Primers 
All primers were designed by using “Primer BLAST” which is available 
online at http://www.ncbi.nlm.nih.gov/tools/primer-blast/. Primer sequences and 
annealing temperatures for PCR analysis are summarized in Table 4. All primers were 
purchased from MWG-Biotech (Ebersberg, Germany) and diluted in 1 X Tris-EDTA 
(pH 8.0) buffer to achieve a final concentration of 100 pmol/µl and stored as stock 
solution at -20°C. 
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Table 4 Information on forward (FP) and reverse primers (RP) used in 
quantitative realtime PCR.  
Gene  Primer Sequences Annealing 
Temperature 
Accession 
No./Reference 
Amplicon 
Size (bp) 
ß2M FP:5´-CCGTGATCTTTCTGGTGCTT-3´ 
RP:5´-AAGTTGGGCTTCCCATTCTC-3´ 
60°C NM_012512 109 
bcl-2 FP:5´-GGGATGCCTTTGTGGAACTA-3´ 
RP:5´-CTCACTTGTGGCCCAGGTAT-3´ 
59.6°C NM_016993 138 
bid FP:5´-CGACGAGGTGAAGACATCCT-3´ 
RP:5´-AGACGTCACGGAGCAGAGAT-3´
59.6°C NM_022684 119 
bax FP:5´-TGTTTGCTGATGGCAACTTC-3´ 59.6°C NM_017059 104 
RP:5´-GATCAGCTCGGGCACTTTAG-3´    
bim FP:5´-AGATACGGATCGCACAGGAG-3´ 59.6°C NM_171989 148 
RP:5´-ACCAGACGGAAGATGAATCG-3´    
bak FP:5´-GGGAAGACCCTCACCTTCTC-3´ 59.6°C NM_053812 142 
RP:5´-ACATTGCAACCAGATCCACA-3´    
UPEC  
P pili 
FP:5´-GACGGCTGTACTGCAGGGTGTG
GCG-3´ 
62.0°C [193] 328 
RP:5´-ATATCCTTTCTGCAGGGATGCA
ATA-3´ 
   
2.2 Methods 
2.2.1 Animals 
19 day old immature Wistar rats (Charles River Laboratories, Sulzfeld, Germany) 
were purchased for Sertoli cell and peritubular cell isolation, while UPEC induced 
epididymo-orchitis model was established with 250~275 g adult male Wistar rats 
(Harlan, Borchen, Germany). The animals were housed in standard conditions (12 h 
light/dark cycle, 20~22°C), with free access to water and food. All experiments 
involving animals were carried out in strict accordance with the recommendations in 
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the Guide for the Care and Use of Laboratory Animals of the German law of animal 
welfare. The protocol was approved by the Committee on the ethics of Animal 
Experiments of the Regierungspraesidium Giessen, Giessen, Germany (permit 
number GI 20/23 –No. 16/2009). All surgery was performed under Ketamine and 
Xylazine anesthesia, and all efforts were made to minimize suffering. 
2.2.2 Bacterial strains and propagation 
Although there is a well known correlation between E. coli infection and male 
infertility, the specific strain involved have yet to be identified [90]. Previously the 
pathogenic E. coli from serotype strain (O6) was frequently employed in high 
concentrations for investigation of the detrimental effects on spermatozoa and for 
establishment of epididymitis model in rat [82,194]. Considering clinical relevance 
and availability of the full genomic sequence, UPEC strain CFT073 (serotype 
O6:K2:H1) was employed for in vivo and in vitro characterization in my study. 
Non-pathogenic commensal E. coli (NPEC) strain 470 served as a negative control 
stain in in vitro studies. HlyA is the main virulence factor accounting for acute 
prostatitis, and may also contribute to UPEC induced sperm membrane disruption 
identified in a series of in vitro studies [82,83,195]. To further explore the potentially 
deleterious effects of HlyA on testicular cells, various E. coli strains possessing 
distinct HlyA expression patterns were employed. UPEC represents strain CFT073 
without statement in the whole experiment.  
UPEC strain CFT073 (NCBI: AE014075, NC_004431) was obtained from Ulrich 
Dobrindt (University of Muenster, Germany). Another pyelonephritic UPEC strain 
536 prevalent in UTIs with acquisition of two α-hemolysin (hlyA) determinants was 
obtained from the same group. NPEC strain 470 was obtained from microbial 
collection of the Institute of Medical Microbiology (University of Giessen, Germany). 
The mutant with deletion of both hlyA determinants in the UPEC 536 strain (hlyA 
double mutant = UPEC 536 HDM) and fosmid carrying clone FOS 22 that spans base 
pairs 3400446 ~ 3433092 of the CFT073 genome enclosing only one hlyA allele were 
constructed as previously described (Sudhanshu B et al. unpublished data). 
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All bacterial strains were propagated over night on Columbia blood agar plates 
(Oxoid, Wesel, Germany). Fosmid carrying clones were propagated in Lysogeny 
broth (LB) agar medium supplemented with 20 µg/ml Cloramphenicol. Fresh cultures 
were inoculated in LB medium and grown to early exponential phase (OD600 = 
0.5~1.0) at 37°C in a shaking incubator. The concentration of viable bacteria was 
calculated using standard growth curves. Bacteria (2×109 cfu) were centrifuged at 
4,500×g for 8 min at room temperature and the pellet was washed once with PBS and 
resuspended in 10 ml saline or RPMI 1640 medium. For in vivo experiments, the 
bacterial suspension was diluted with sterile saline to achieve 4 ×106 cfu bacteria in 
100 µl. For in vitro experiment, bacterial suspension was prepared with the 
concentration of 2×108 cfu/ml. The volume of bacterial suspension employed could 
be scaled up or down depending on the number of cells. For example, 100 µl bacterial 
suspension were added in one well of a 6-well cell culture plate with 1 million cells 
(Multiplicity of infection, MOI = 20).  
2.2.3 UPEC induced epididymo-orchitis rat model  
The adult male Wistar rats (250~275 g) were anaesthetized with 50 mg/ml 
Ketamine and 2% Xylazine (v:v=7:3). After general anesthesia, the scrotum incision 
was made to expose the testis, epididymis and vas deferens. 100 µl of UPEC 
CFT073-saline suspension (about 4×106 bacteria) for each side was injected to the vas 
deferens using 30-gauge needles. As a control group, the same volume of saline was 
injected into the sham operated rats. The vasa deferentia were ligated at the site of 
injection to prevent spreading of infection. An injection was considered to be 
successful when the vas deferens dilatation followed by the cauda epididymis became 
transparent, and without leakage of the fluid from the site of injection. After operation, 
animals were kept in standard condition until being sacrificed.  
Rats were killed with an overdose of isoflurane in the morning of day 7. Both 
testicles and epididymides were removed aseptically, followed with the measurement 
of the weight and volume of these organs. The testis and epididymis from one side 
were fixed in Bouin’s fluid (75 ml picric acid solution + 25 ml 37% formaldehyde 
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solution + 5 ml acetic acid), and the organs from the other side were preserved at 
-80°C. Before placement of each testicle into fixative, the tunica albuginea was 
shallowly punctured at each pole 3 times with a 24-gauge needle to facilitate the 
penetration of fixative.  
For sperm concentration measurement, the cauda epididymis was homogenized in 
5 ml of saline and sperm counting was performed using a Neubauer® camera. This 
data was collected and kindly provided by Dr. Marcelo Marconi who took part in the 
establishment of this epididymo-orchitis model in our group.   
2.2.4 UPEC detection in the testis  
2.2.4.1 Detection of UPEC P pili gene expression in the testis using PCR 
DNA was isolated from the testes of saline injected control animals and UPEC 
infected rats with QIAamp® DNA Mini kit (Qiagen, Venlo, The Netherlands). Up to 
25 mg of frozen testis from each sample was minced into small pieces and collected 
in 1.5 ml Eppendorf tube. 180 µl ATL buffer and 20 µl proteinase K were added into 
the tube for incubation at 56°C in shaking block until tissue was completely lysed. To 
eliminate possible contamination of RNA, the sample was incubated for 2 min at 
room temperature with 4 µl RNase A (100 mg/ml). 200 µl AL buffer was added to the 
sample, followed by pulse-vortexing for 15 min and incubation at 70°C for 10 min. 
200 µl ethanol (96~100%) was added to the sample and mixed by vortexing for 15 sec. 
The mixture was transferred to the QIAamp Mini spin column in a 2 ml collection 
tube. The column was centrifuged at 6082×g for 1 min and placed in a new collection 
tube. Then 500 µl AW1 buffer was added into the column for washing and followed 
by centrifugation at 6082×g for 1 min. Placed into a new collection tube, the column 
was washed again with 500 µl AW2 buffer and centrifuged at full speed (16060×g) 
for 1 min. QIAamp Mini spin column was placed in a fresh 1.5 ml collection tube; 
200 µl AE buffer was added into it and incubated at room temperature for 1 min. The 
DNA was eluted by centrifugation at 6082×g for 1 min. After the measurement of 
DNA concentration with spectrophotometer, a certain amount of DNA sample was 
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diluted with DNA/RNase free water to generate an aliquot with concentration of 200 
ng/µl. Together with specific primers (shown in Table 4), 1 µl of such an aliquot from 
each sample was used for further PCR reaction to detect the expression of UPEC P 
pili gene. The reaction system is described as below. The PCR product was 
electrophoresed on 1.5% agarose gel. DNA sample isolated from the testis into which 
UPEC suspension was directly injected served as a positive control.  
 
Component  Volume  
DNA (200 ng/µl) 1.0 μl  
Forward Primer (10 pmol/µl) 0.5 μl  
Reverse Primer (10 pmol/µl) 0.5 μl 
2X Bio-Rad SYBR green mix 12.5 μl 
DNA/RNase-free water  10.5 μl  
2.2.4.2 Streaking of testis homogenate on agar plate 
One testis from saline injected control and UPEC infected rat was homogenized 
in 10 ml sterile PBS with the sterile glass potter. 100 µl of the testis homogenate from 
each sample was streaked on agar plate and incubated overnight at 37°C. Bacterial 
colonies were checked the next morning under translucent light. 
2.2.4.3 Fluorescent and electron microscopy for UPEC detection inside the testis 
(described in 2.2.13 and 2.2.7, respectively)  
2.2.5 Histopathology and Hematoxylin & Eosin staining  
After fixation in Bouin’s fluid for 24 h, the testes and epididymides samples were 
transferred into 70% ethanol which was changed 3~4 times every day until the yellow 
color of Bouin’s fluid completely disappeared. Tissues were hydrated serially in 80%, 
90% and 100% ethanol and stored in isopropanol overnight at 60°C before embedding 
in paraffin. Paraffin sections were prepared at 8 µm thickness. 
Paraffin sections were kept in incubator for 30 min at 60°C before deparaffinized 
in 2 changes of xylene. After deparaffinization, sections were re-hydrated serially in 
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absolute ethanol (2 times with 10 min each), 90% (10 min), 80% (10 min), 70% (30 
min) and 50% (10 min) ethanol, and then rinsed briefly in distilled water. Slides were 
immersed into Harris hematoxylin solution for 10 min, subsequently washed in 
distilled water for a while and differentiated in 1% hydrochloric acid for 30 sec, then 
immersed in 0.2% ammonia water for 30 sec to 1 min. After washing in running tap 
water for 10 min, sections were counterstained in 0.2% eosin Y solution for 30 sec to 
1 min.  Sections were washed in distilled water and followed by serial dehydration 
through 50%, 70%, 80%, 90% ethanol and absolute alcohol. Slides were cleaned in 3 
changes of xylene (10 min each), and then mounted with xylene based mounting 
medium (Merck, Darmstadt).  
2.2.6 TUNEL assay 
DNA fragmentation in the testis was semi-quantitatively examined with Terminal 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay, which is able 
to enzymatically label the free 3’-OH termini of DNA strand breaks associated with 
apoptosis.  
Sections of frozen and paraffin embedded testis were pretreated differently before 
TUNEL assay. Cryosections of the testes were fixed with 1% paraformaldehyde-PBS 
(pH 7.4) in a coplin jar for 10 min at room temperature, and post-fixed in precooled 
ethanol: acetic acid, 2:1 (v:v) for 5 min at -20°C to permeabilize cells. Sections were 
washed 2 times with PBS before proceeding. Paraffin embedded testis sections 
needed to be deparaffinized with xylene, and subsequently re-hydrated serially in 
100%, 95% and 70% ethanol. To eliminate unspecific binding of nucleotides or 
enzyme conjugate, paraffin sections were treated with freshly prepared proteinase K 
(20 μg/ml) for 15 min digestion at room temperature, followed by 2 times washing 
with PBS. A positive control sample was prepared from the testis sample by treating 
with DNase I as follows. The testis section was pretreated with DN Buffer (30 mM 
Trizma base, pH 7.2, 4 mM MgCl2, 0.1 mM DTT) at room temperature for 5 min, 
followed by incubation with DNase I in DN Buffer (specific activity is 10,000 U/ml - 
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1,000 U/ml) for 10 min at room temperature. Section was ready for TUNEL assay 
after 5 times rinsing with dH2O.  
Excess liquid was carefully removed from sections; equilibration buffer was 
immediately added directly on the specimen for at least 10 sec at room temperature. 
Sections were subsequently incubated with working strength TdT enzyme (77 µl 
Reaction Buffer + 33 μl TdT Enzyme) in a humidified chamber at 37°C for 1 h. Then 
slides were washed with working strength/wash buffer (1 ml Stop/Wash Buffer + 34 
ml dH2O) and PBS to terminate the reaction. For visualizing DNA damage, sections 
were incubated with anti-Digoxigenin-fluorescein conjugated antibody [Blocking 
Solution: Anti-Digoxigenin Conjugate, 53:47 (v:v)] in a humidified chamber for 30 
min at room temperature in dark. After briefly washing with PBS, sections were 
mounted with Vectashield® mounting medium containing DAPI (Vector Laboratories 
Inc, CA, USA). TUNEL positive cells were finally examined with Fluorescent 
microscope Axioplan 2 Imaging system (Carl Zeiss, Göttingen, Germany) using 
512~542 nm filter. 
2.2.7 Electron microscopy 
Animals were anesthetized with 50 mg/ml Ketamine and 2% Xylazine (v:v=7:3) 
followed by perfusion with 0.9% NaCl plus Heparin (25000 IE/5ml) via left ventricle. 
A solution containing 2% glutaraldehyde and 2% formaldehyde in 0.1 mol/l sodium 
cacodylate buffer (pH 7.3) was used for fixation. The identical fixative additionally 
contained 1% lanthanum nitrate for demonstration of blood-testis barrier and 
blood-epididymis barrier. Specimens of the testes and epididymides (1 mm3) were 
fixed in fixative for 1 h, and post fixed in 1% osmium tetroxide for 3 h. Tissue blocks 
were embedded in Epon 812 following dehydration. Semithin sections (1 µm) were 
stained with toluidine blue, mounted in Eukitt (Riedel-de Haen, Seelze, Germany) and 
imaged in light microscope. Ultrathin sections (60 nm) were double stained with 
uranyl acetate and lead citrate for electron microscopy examination  
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2.2.8 Isolation of Sertoli and peritubular cells 
Medium: 
PBS-A 
500 ml PBS Dulbecco’s without Ca2+ and Mg2+  
 5 ml 100X Penicillin & Streptomycin 
750 mg D-Glucose (dissolved in 5ml of PBS and solution was passed through a 
0.20 µm filter into 500 ml PBS bottle) 
Trypsin-DNase-Solution in PBS 
10 ml PBS-A 
25 mg Trypsin 
200 µg DNase I 
Trypsin inhibiter-Solution A in PBS-A  
5 ml PBS-A 
50 mg Trypsin inhibiter 
Trypsin inhibiter-Solution B in PBS-A  
10 ml PBS-A 
25 mg Trypsin inhibitor 
 Collagenase-Hyaluronidase-DNase-Solution in PBS-A 
10 ml PBS-A 
10 mg Collagenase  
10 mg Hyaluronidase  
200 µg DNase I  
Hyaluronidase-DNase-Solution in PBS-A 
10 ml PBS-A 
10 mg Hyaluronidase  
200 µg DNase I  
All enzyme solvents above were sterilized by passing through a 0.20 µm filter 
(SARSTEDT, Nuembrecht, Germany). 
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Sertoli cell culture medium 
 500 ml RPMI-1640 medium with L-glutamine   
 5 ml 100X Penicillin & Streptomycin   
Peritubular cell culture medium 
 500 ml RPMI-1640 medium with L-glutamine  
 5 ml 100X Penicillin & Streptomycin  
50 ml Fetal Bovine Calf Serum  
Sertoli and peritubular cells were isolated from 19-day old Wistar rats. Ten young 
rats were sacrificed by cervical dislocation and the twenty testes were collected via 
abdominal incision and stored in 20 ml PBS-A. After disinfection with 1% 
iodine-ethanol, all testes were washed 2~3 times with PBS-A. Each testis was 
decapsulated by grasping one end with forceps and making a small incision on the 
tunica albuginea of the other end with a scissor. Seminiferous tubules were pushed out 
and digested with 10 ml Trypsin-DNase-Solution at 32°C in shaking water bath (120 
oscillations/min) for 5~10 min. When seminiferous tubules were properly separated, 
trypsin digestion was terminated by adding Trypsin inhibitor solution A (10 mg/ml) 
and B (2.5 mg/ml) in sequence. Seminiferous tubules were washed 8 times with 
PBS-A to get rid of contaminating interstitial cells, followed by incubation with    
Collagenase-Hyaluronidase-DNase-Solution at 32°C in shaking water bath (120 
oscillations/min) for 10~15 min. Incubation was stopped when peritubular cells were 
free from tubules. Tubular fragments were settled down and the supernatant enriched 
with peritubular cells was transferred to a new 50 ml falcon tube. Peritubular cells 
were collected by centrifugation at 280×g for 10 min and resuspended with RPMI 
1640 medium (supplemented with 10% FCS). Cells were divided and seeded into 5 
cell culture flasks (75 cm2) and cultured at 37°C with 5% CO2. On the 3rd day after 
cell isolation, peritubular cells were split and seeded into 10 flasks. Cell splitting was 
repeated every two days. Two days before experiments, 5×105 cells / well were plated 
into 6-well plates and cultured with 10% FCS RPMI 1640 medium. Before 
experiments peritubular cells were starved overnight by culture in RPMI 1640 
medium with 1% FCS.  
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For Sertoli cell isolation, remaining tubular fragments were digested with 10 ml 
of Hyaluronidase-DNase-Solution at 32°C in shaking water bath (120 oscillations/min) 
for 8~10 min. To control the timing of digestion, the digested tubular fragments were 
monitored under the microscope. The digestion of tubules should be stopped when 
tubular fragments become very short and mainly consisting of individual cells. The 
fragmented tubules were further washed for 5 times with PBS-A to get rid of 
contaminating germ cells and PTC. After the last wash, SC enriched fraction was 
dispersed by passing through an 18G needle 10 times using a 20ml syringe. Cells 
were spinned down by centrifugation at 300×g for 10 min. The supernatant was 
discarded and cell pellet was resuspended in 15 ml RPMI 1640 medium. The cell 
suspension was subsequently filtered with 70 µm nylon filter (BD Falcon, NY, USA) 
to remove the undigested tubular fragments. 3 × 106 cells / well were seeded in 6-well 
plates and incubated at 32°C with 5% CO2. Cell numbers were adapted for culture in 
12-well and 24-well plates. To remove contaminating germ cells the hypotonic shock 
treatment was applied on the 3rd day of culture. Briefly, SC were rinsed two times 
with PBS and incubated with 20 mM Tris-HCl (pH 7.5) for 1 min. Again cells were 
washed twice with PBS and cultured for three more days in RPMI 1640 medium. On 
the 6th day SC was ready for experiments.  
 Purity of PTC and SC preparations was estimated > 95% by immunofluorescence 
using antibodies directed against α-smooth muscle actin (for PTC) and vimentin (for 
SC).  
2.2.9 cDNA synthesis and quantitative real-time PCR (qRT-PCR) 
2.2.9.1 Isolation of RNA 
Total RNA was extracted from the testes of control and infected rats as well as 
from SC and PTC samples with RNeasy mini kit (Qiagen, Venlo, The Netherlands). 
About 20~30 mg frozen tissue from each testis sample was homogenized in 600 µl 
RLT buffer using a TissueLyser. When UPEC infection experiments were finished, 
the Sertoli and peritubular cells grown in culture plates were collected into up to 600 
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µl RLT buffer by using cell scrapers after twice washing with PBS. Cells clumps were 
disrupted by passing 5~10 times through a 21-gauge needle fitted to a 1 ml syringe. 
The lysate was centrifuged at 16,060×g for 3 min; the supernatant was transferred to a 
new Eppendorf tube and mixed with 1 volume of 70% ethanol thoroughly. Up to 700 
µl of the mixture each time was transferred to an RNeasy spin column placed in a 2 
ml collection tube for centrifugation at 16,060×g for 15 sec. The flow-through was 
discarded after every centrifugation and 700 µl RW1 buffer was added to the spin 
column to wash column membrane by centrifuging at top speed for 15 sec. The 
collection tube was emptied completely and 500 µl RPE buffer was added to the 
column. The spin column was centrifuged for 15 sec at 16,060×g. The RPE buffer 
washing step was repeated followed by a centrifugation at full speed for 2 min. To 
eliminate any possible carryover RPE buffer, the column was placed in a new 2 ml 
collection tube and centrifuged at full speed for 1 min. The RNeasy spin column was 
placed in a new 1.5 ml collection tube, 30~40 µl RNase-free water was directly added 
to the column membrane. The RNA was eluted by centrifuging at 16,060×g for 1 min. 
RNA concentration of each sample was measured with a spectrophotometer.  
2.2.9.2 DNA digestion  
Prior to RT-PCR amplification, putative contamination of genomic DNA was 
eliminated by DNase I (Invitrogen, CA, USA) treatment. Two µg RNA from each 
sample was treated with 2 µl DNase I at room temperature for 15 min in the reaction 
mixture given below. The DNase I was inactivated by addition of 2 µl of 25 mM 
EDTA (pH 8.0) solution to each sample and subsequent heating at 65°C for 10 min.  
DNase digestion reaction mix: 
 
 
 
 
Component Volume 
2 μg RNA X μl 
DNase I (1 U/μl) 2 μl 
10 X DNase I buffer 2.0 μl 
RNase free water to 20 μl 
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To make sure RNA samples were free of DNA contamination, each DNase I 
digested RNA sample was amplified by standard PCR to detect the expression of 
housekeeping gene (beta-2-microglobulin, ß2M). The absence of PCR product was 
verified on agarose gel. 
2.2.9.3 Reverse transcription  
Reverse transcription of each DNase I digested RNA sample was carried out 
sequentially by using Moloney Murine Leukemia Virus Reverse Transcriptase 
(M-MLV RT) and Oligo (dT) 15 Primer (Promega, Wisconsin, USA). For each 
sample, 2 µg of RNA was mixed with 2 µl of Oligo (dT) 15 Primer in a reaction 
volume of 22 µl, and then denatured at 70°C for 10 min.  
 Denaturation of RNA and primer annealing: 
Component Volume 
2 μg of DNase I digested RNA  20 μl 
Oligo dT
15
 2 μl 
 
After denaturation, samples were snap chilled on ice for 2 min. A RT mix was 
prepared as below and added to RNA & Oligo (dT) primer mixture.  
RT mix: 
Component  Volume  
5 X M-MLV RT buffer  8 μl  
dNTP Mix (A,C, G and T, each 10 mM)  2 μl  
RNAsin (RNase inhibitor, 40 U/μl)  1 μl  
RNase-free water  6 μl  
The samples were preheated at 42°C for 2 min. 1 μl of reverse transcriptase 
(M-MLV RNase H-minus, 200 U/μl) was subsequently added to each sample in a 
total reaction volume of 40 µl. The reaction mix was incubated at 42°C for 75 min, 
followed with inactivation of reverse transcriptase by incubating samples at 72°C for 
15 min. cDNA Samples were stored at -20°C. 
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2.2.9.4 Quantitative realtime PCR  
The reagents of qRT-PCR differ from a normal PCR with addition of the double 
strands DNA (dsDNA) specific fluorescent reporter probes (such as SYBR green in 
this project). The reporter probes are able to bind to all dsDNA during polymerization 
and emit fluorescence. The increasing fluorescence signal that corresponds to the 
exponential increase of DNA product in each cycle can be detected and recorded in 
the real-time PCR thermocycler, which is used to determine the threshold cycle (Ct) 
value and facilitates quantifying gene expression.  
For the detection of bcl-2, bid, bax, bim and bax expression, primers pairs were 
designed by “Primer BLAST” and synthesized by Eurofins MWG Operon. Gradient 
PCR was employed to determine the optimal annealing temperature for individual 
genes. The detailed information of these primers is shown in Table 4. The 
amplification efficiencies of these primers were estimated by the dilution method. All 
primers’ efficiencies were between (100 ± 15)%. A typical 25 µl qRT-PCR reaction 
mix is described below.  
 
 
 
 
 
 
Realtime PCR amplification with iQTM SYBR® Green Supermix was performed 
in triplicate by using the iCycler iQ® System (Bio-Rad, CA, USA) according to 
manufacturer’s procedure. Cycling conditions were described as below: after an initial 
activation step at 95°C for 8 min, 45 cycles of denaturation (95°C for 20 sec), 
annealing (see Table 4), and extension (72°C for 30 sec) were performed. 
The PCR products were examined using agarose gel electrophoresis for specific 
amplification. The relative quantification of PCR products was determined by the 
Component Volume per reaction 
cDNA 1 µl 
2X iQ SYBR green supermix 12.5 µl 
Forward and reverse primer mix (10 pM/µl) 1 µl 
DNase/RNase free water 10.5 µl 
Total volume 25 µl 
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comparative Ct method. The target genes expression is normalized to the 
non-regulated reference gene ß-2 microglobulin (ß2M).  
2.2.9.5 Agarose gel electrophoresis  
6 X gel loading buffer with Bromophenol blue  
0.25% (w/v) Bromophenol blue  
30% Glycerol in H2O 
50 X TAE electrophoresis buffer (1L, pH 8.0)  
242 g of Tris base  
57.1 ml of glacial acetic acid  
100 ml of 0.5 M EDTA  
1X TE buffer 
10 mM Tris-HCl pH 8.0  
1 mM EDTA  
Ethidium bromide (0.5 µg/ml) 
2.2.10 MTT assay for cell viability measurement  
To determinate the cytotoxic effect of bacterial (UPEC CFT073, UPEC 536, 
NPEC 470, UPEC 536 HDM and FOS 22) infection, the viability of SC and PTC was 
measured with MTT [3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] 
assay. After 2 h bacterial treatment, cells were washed two times with pre-warmed 
MEM medium without phenol red. 0.5 mg/ml MTT working solution (in MEM 
medium) was added into wells being assayed (0.5 ml for each well of 24-well plate) 
for 1.5 h at 37°C. During this period, formazan crystals formed only within living 
cells, which indicating cell metabolic activity. Then 0.5 ml of DMSO was added to 
each well and mixed thoroughly to dissolve all the dark blue crystals at the bottom of 
each well. The absorbance is read by spectrophotometer, using 570 nm as test 
wavelength and 650 nm as the reference wavelength. The absorbance proportionally 
corresponding to cell viability and the result is expressed as a ratio of the treated cells 
compared to the untreated control: (A570 –A650) of treated cell/ (A570 –A650) of 
non-treated cells ×100%.).   
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2.2.11 Annexin V/PI staining 
As an early event of apoptosis, the membrane phospholipid phosphatidylserine 
(PS) is translocated from the inner to the outer leaflet of apoptotic cell membrane, 
indicating the loss of plasma membrane. Annexin V is a phospholipid binding protein 
which has a high affinity for PS. Fluorochromes conjugated Annexin V retains such a 
binding affinity and can serve as a sensitive probe for quantitative analysis of 
apoptotic cells. Early apoptosis in SC and PTC after infection was evaluated by 
measuring the exposure of PS on the cell membranes by using FITC Annexin V 
apoptosis detection kit I (BD Biosciences, NJ, USA). After bacterial infection, cells 
were rinsed twice with PBS, and detached with Trypsin-EDTA. Cells were 
subsequently resuspended in 1 X working buffer at a concentration of 1×106 cells/ml. 
100 µl of cells suspension was transferred to 5 ml culture tube and mixed with 2.5 µl 
of Annexin V and 2.5 µl propidium iodide (PI). The cells suspension was gently 
vortexed and incubated for 15 min in dark. After incubation, 400 µl of 1 X binding 
buffer was added to each tube to stop to the reaction. The population of Annexin V 
positive cells was evaluated by flow cytometry (BD FACScan, Becton Dickinson 
Immnunocytometry Systems, CA, USA) within 1 h. Samples were gated on the basis 
of forward versus side scatter for size, and the results are presented as the percentage 
of cells those were viable (Annexin V- PI-), early apoptotic (Annexin V+ PI-), late 
apoptotic or necrotic (Annexin V+ PI+) and damaged (Annexin V- PI+). 
2.2.12 Immunoblotting 
2.2.12.1 Buffers and solutions 
10 X Tris buffered saline (TBS) 
24.2 g Tris base 
80 g NaCl 
Dissolved in 1L water, pH to 7.4 
with HCl 
 
Washing buffer TBS/T  
1 X TBS  
0.1% (v/v) Tween-20 
30% Acrylamide solution 
Acrylamide/Bisacrylamide 
=37.5:1 
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RIPA buffer  
25 mM Tris-HCl pH 7.6 
150 mM NaCl 
1% NP-40 
1% Sodium deoxycholate  
0.1% SDS 
100 X Proteinase inhibitor cocktail 
(Sigma) * 
* Added fresh just before cell 
lysis  
Protein gel sample loading buffer 
50 mM Tris-HCl; pH 6.8   
2% SDS  
10% Glycerol   
1% β-Mercaptoethanol   
12.5 mM EDTA  
0.02 % (w/v) Bromophenol Blue  
10 X Phosphate buffered saline (PBS)  
4 g KCl 
4 g KH2PO4 
160 g NaC 
23 g Na2HPO4 * H2O 
Dissolved in 1L H2O, pH to 7.4 
with HCl 
Blocking buffer 
10 X Electrophoresis buffer (pH 8.3) 
30.3 g Tris base 
 144 g Glycine 
 10 g SDS 
Dissolved in 1L water, set pH to 
8.3 with HCl 
Stripping buffer 
 6.25 ml 1 M Tris HCl 
 2 ml 10% SDS 
 700 µl β-mercaptoethanol* 
Make volume up to 100 ml with 
water 
* Added freshly just before 
stripping of membrane 
Cathode buffer 
25 mM Tris 
40 mM 6-amino-hexanoic acid  
20% (v/v) Methanol  
10 X Anode buffer 
300 mM Tris 
20% (v/v) Methanol 
1 X Anode buffer 
30 mM Tris 
20% (v/v) Methanol 
0.1 ml Tween-20 
5 g Non fat dry milk 
100 ml 1 X TBS 
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Separating gel: 
 7.5%* 10%* 12.5%* 15%* 
Water 4.85 ml 4.01 ml 3.17 ml 2.35 ml 
1.5 M Tris-HCl pH 8.8 2.5 ml 2.5 ml 2.5 ml 2.5 ml 
10% (w/v) SDS 100 µl 100 µl 100 µl 100µl 
Acrylamid 2.5 ml 3.34 ml 4.17 ml 5 ml 
10% (w/v) APS** 50 µl 50 µl 50 µl 50 µl 
TEMED 5 µl 5 µl 5 µl 5 µl 
Total 10 ml 10 ml 10 ml 10 ml 
 
 
Stacking gel: 
 
 
 
 
 
 
* Separating gels with different percentages were used according to the molecular 
weight of target proteins (based on 37.5:1 acrylamide/bisacrylamide ratio). 7.5% gel: 
250~120 kDa; 10% gel: 120~40 kDa; 12.5% gel: 40~15 kDa; 15% gel: < 20 kDa.  
** Ammoniumpersulfate (APS) was prepared fresh before each experiment. 
2.2.12.2 Western blotting 
After treatment with bacteria, cells were harvested by scraping them into RIPA 
lysis buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% Sodium 
deoxycholate and 0.1% SDS) supplemented with proteinase cocktail inhibitor. The 
concentration of protein in cell lysates was determined by the Bradford Method 
(Bio-Rad, Munich, Germany). Thirty µg protein of each sample was resolved on 
SDS-polyacrylamide gel and protein was electrophoretically transferred onto a 0.2 µm 
pore size nitrocellulose membrane (HybondTM ECLTM, GE Healthcare, UK) by using 
a PerfectBlueTM semidry electroblotter (PeqLab Biotechnologie, Germany). The 
nonspecific binding sites were blocked by incubating the membranes in 5% non-fat 
 4%* 
Water 3 ml 
0.5 M Tris-HCl pH 6.8 1.25 ml 
10% (w/v) SDS 50 µl 
Acrylamide 0.65 ml 
10% (w/v) APS** 25 µl 
TEMED 5 µl 
Total 5 ml 
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milk in Tris-buffered saline (TBS) with 0.1% Tween (TBS-T) for 1 h at room 
temperature. The membranes were subsequently incubated with primary antibodies 
(Table 2) in blocking solution overnight at 4°C and then rinsed three times with 
TBS-T. Membranes were incubated with anti-mouse or anti-rabbit antibody 
conjugated with HRP (Table 3) for 1 h at room temperature and then rinsed three 
times with TBS-T for 10 min. Immunoreactive proteins were detected using an ECL 
Kit (ImmobilonTM Western Chemiluminescent HRP substrate, Millipore corporation, 
Billeria, MA, USA), according to the manufacturer’s instructions.  
2.2.13 Immunofluorescent staining 
10 µm thick frozen tissue sections or cells grown on coverslips were fixed with 
precooled 4% PFA for 20 min. Then samples were permeabilized with 0.2% 
Trition-X 100 at room temperature. After 3 times washing with PBS, tissue sections 
or cells were incubated with blocking agent (5% BSA + 5% normal horse/sheep 
serum) for 1 h at room temperature, followed by incubation with primary antibodies 
(Table 2) at 4°C overnight. Samples were rinsed thoroughly and incubated with anti 
rabbit or anti mouse Cy-3 conjugated secondary antibody (Table 3) with 1:1000 
dilution for 1 h at room temperature in dark. For confocal microscopy analysis, cell 
nuclei were counterstained with Cy5-conjugated To-Pro-3 (Invitrogen, Karlsruhe) for 
15 min. Slides or cells were washed 3 times with PBS for 5 min each, and then 
mounted with Vectashield ® mounting medium containing DAPI. Samples were 
finally examined with Fluorescent microscope Axioplan 2 Imaging system or TCS 
SP2 confocal scanning microscope (Leica Microsystems, Wetzlar, Germany). 
2.2.14 Calpain activation analysis 
7-amino-4-chloromethylcoumarin, t-BOC-L-leucyl-L-methionine amide (CMAC, 
t-Boc-Leu-Met) is a cell-permeable fluorogenic calpains substrate, which can emit 
blue-fluorescence with excitation/emission at 351/430 nm after cleaved by activated 
calpains. SC and PTC cultured on cover slides were pre-incubated for 30 min with 50 
mM and 100 µM of this calpain substrate in RPMI 1640 medium, and then cells were 
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treated with UPEC (MOI = 20) for 30 min. Calpain activation within cells was 
observed in a Zeiss fluorescence microscope with filter of 420~460 nm wavelength. 
2.2.15 Reactive oxygen species (ROS) level measurement 
H2DCF-DA (2', 7'-dichlorodihydrofluorescein diacetate) is a cell-permeable 
indicator for ROS, which is non-fluorescent until the acetate groups are removed by 
intracellular esterases and oxidation occurs within the cell. 
To detect the ROS production in UPEC infected SC and PTC, cells were 
pretreated with 10 µg/ml H2DCF-DA for 30 min. The medium was replaced with 
fresh culture medium without antibiotic and cells were treated with UPEC CFT073 or 
NPEC 470 (MOI = 20) for different time points. After infection, cells were detached 
with Trypsin-EDTA and suspended in PBS at a concentration of 1×106 cells/ml. 500 
µl cell suspension of each sample was prepared in culture tube for flow cytometry 
analysis.  
2.2.16 Intracellular ATP determination 
Intracellular ATP release from SC and PTC cells were determined by 
luciferin-luciferase assay using a bioluminescence analyzer. Bioluminescence 
determination of ATP was performed by using ATP assay mix and dilution buffer. 
ATP assay mix contains luciferase and luciferin. ATP assay mix dilution buffer 
contains MgSO4, DTT, EDTA, bovine serum albumin and tricine buffer salts. The 
basic principle of this reaction can be explained by the below equation: 
 
 
    
 
 
Reaction (1) is reversible and reaction (2) is irreversible. The light emitted is 
proportional to ATP present in the sample. 
Firefly luciferase 
      Mg2+ 
ATP + Luciferin Adenyl-luciferin + PPi      (1) 
Adenyl-luciferin + O2 Oxyluciferin + AMP + CO2 + light   (2) 
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SC and PTC grown to confluence in 12 well plates were treated with UPEC 
CFT073 (MOI = 20) for up to 4 h. Each hour cells were washed to remove excess of 
bacteria. After treatment cells were washed 3 times with PBS and subsequently lysed 
with 150 µl of boiling lysis buffer (100 mM Tris-HCl, pH 7.75, 4 mM EDTA) and 
boiled for an additional 2 min to inactivate ATPase. Lysates were then centrifuged at 
3600×g to remove cell debris and the supernatants were kept on ice for measurement. 
ATP levels were assayed using an ATP Bioluminescent Assay kit (Sigma), where 100 
µl of luciferase reagent mix (50 µl of ATP assay mix + 1.5 ml of ATP assay mix 
dilution buffer) was added to 100 µl of lysate by automated injection and the 
luminescence read immediately with 1 sec integration, using a microplate reader 
(Berthold, Bad Wildbad, Germany). Intracellular ATP level of the untreated cells 
lysate was set to 100% and those of infected samples were normalized with of the 
untreated control sample. 
2.2.17 Isolation and analysis of genomic DNA degradation  
Cell lysis buffer 
 50 mM Tris-HCl (pH 8.0) 
 400 mM NaCl 
 100 mM EDTA 
 0.5% SDS 
 0.5 mg/ml proteinase K* 
 * Added fresh before digestion 
Proteinase k (20 mg/ml) stock solution 
20 mg of proteinase K was dissolved in sterile 1 ml solution with 50 mM Tris 
(pH 8.0) and 1.5 mM calcium acetate to get a concentration of 20 mg/ml. 
RNase A (10 mg/ml) stock solution 
10 mg RNase A was dissolved in 0.9 ml of 0.01 M sodium acetate (pH 5.2). The 
solution was heated to 100°C for 15 min to inactivate potentially contaminated DNase. 
After cooling down to room temperature, pH was adjusted by adding 0.1 ml of 1 M 
Tris-CI (pH 7.4). 
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6 X DNA loading buffer with Orange G  
1% (w/v) Orange G  
40% sucrose 
After bacterial treatment, cells were washed once with PBS and harvested by 
centrifugation at 856×g for 5 min. The cell pellet or minced testis tissue was 
resuspended in lysis buffer (50 mM Tris-HCl; 400 mM NaCl; 100 mM EDTA; 0.5% 
SDS; 0.5 mg/ml proteinase K, pH 8.0) and incubated overnight at 55°C in a shaking 
heating block (1000 rpm). 1/3 volume of 5 M NaCl was added to each sample and 
followed by vigorous shaking for 15 sec. The precipitated protein was spinned down 
by centrifugation at 16060×g for 5 min. The supernatant containing nuclear acid was 
transferred to new 1.5 ml Eppendorf tubes and mixed properly with 1 volume of 
100% ethanol. The DNA was then precipitated by centrifugation at 16060×g for 5 
min and the pellet was washed with 70% ethanol. After subsequent centrifugation for 
5 min at highest speed, ethanol was removed and the tubes were placed with open lids 
in the heating block at 37°C for 10~15 min for air drying. The DNA samples were 
dissolved in 1 X TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH8.0) and treated with 
100 µl/ml DNase-free RNase A at 37°C for 1 h. Again DNA was precipitated and 
redissolved in TE buffer. Concentration of DNA samples was measured with 
spectrophotometer and equal amount of DNA samples were electrophoretically 
separated on 1.5% agarose gels and stained with ethidium bromide.   
A positive apoptosis control for DNA laddering was generated by treating RAW 
264.7 macrophage with 0.5 mM H2O2 for 24 h. Necrosis on RAW 264.7 macrophage 
was induced by repeated freeze – thaw cycles, which can cause random DNA 
degradation and results in “DNA smear” on agarose gel. 
2.2.18 Hoechst 33342 staining  
Hoechst 33342 is a fluorescent stain for labeling DNA and therefore commonly 
used to visualize nuclei structure. To observe the nuclei structure changes in infected 
SC and PTC, cells were seeded on coverslips in 24-well plates for bacteria 
experiments. After bacterial infection cells were washed two times with PBS and 
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incubated with Hoechst 33342 (1:500 in 1% BSA) at 37°C for 10 min. Then cells 
were again washed briefly with PBS and the cover slips were mounted on slides with 
glycerol. Nuclear structure was evaluated with Zeiss fluorescent microscope with the 
filter of 420~460 nm wavelength.  
2.2.19 Caspase-3 enzyme activity assay  
During cell death by apoptosis, activated caspase-3 recognizes the amino acid 
sequence Asp-Glu-Val-Asp (DEVD) within the DNA repairing enzyme PARP1 
[poly(ADP-ribose) polymerase 1] and cleaves this DEVD sequence, resulting the 
inactivation of PARP1. The DEVD labeled with the chromophore p-nitroaniline (pNA) 
can still be specifically recognized and cleaved by caspase-3 and is widely used as a 
colorimetric substrate (DEVD- pNA) for this enzyme activity assay. After cleavage 
from DEVD- pNA, the light emission from pNA can be detected by 
spectrophotometer at 400 nm, the intensity of which is corresponding to the activity of 
caspase-3. To make sure whether UPEC infection caused caspase-3 activation or just 
degradation in PTC, the caspase-3 activity was measured with the Caspase-3/CPP32 
Colorimetric Assay Kit (BioVision, CA, USA) based on the principle described above. 
Briefly, about 3 × 106 PTC of each sample were collected after UPEC treatment and 
resuspended in 50 µl of ice cold Cell Lysis Buffer. After 10 min incubation on ice, the 
samples were centrifuge at 10,000×g for 1 min. The supernatant was transferred into a 
fresh tube and the protein concentration was determined with Bradford assay. 100 µg 
of protein from each sample was diluted with Cell Lysis Buffer to 50 µl and mixed 
with 50 µl of 2X Reaction Buffer containing 10 mM DTT. 5 µl of 4 mM DEVD- pNA 
substrate was added into each sample and incubated at 37°C for 2 h. All samples were 
transferred into a 100-µl micro quartz cuvette and the absorbance was measured with 
a spectrophotometer at 400 nm. The caspase-3 activity was present as the optical 
density (OD400).  
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3 RESULTS 
3.1 Morphological changes in the epididymis and testis of UPEC infected rat  
A UPEC induced in vivo epididymo-orchitis rat model was successfully 
established by injecting UPEC strain CFT073 bilaterally in vasa deferentia. Seven 
days after infection, swollen caudae epididymides, atrophic and inflamed testes with 
increased vascularization and vasocongestion were observed in UPEC injected rats 
(Figure 3A). Accordingly, the weight of bilateral testes was decreased about 30% in 
UPEC infected rats compared to the saline injected control animals (left: 1.02 ± 0.28 
vs. 1.63 ± 0.09 g; right: 1.09 ± 0.36 vs. 1.61 ± 0.10 g, p < 0.001; Figure 3 B).  
 
 
Figure 3 Morphological changes of the epididymis and testis in the rat 
epididymo-orchitis model. (A) A typical appearance of epididymides and testes from 
saline injected (left panel) and UPEC infected rats (right panel) are shown. (B) The 
testicular weight of control (n=8) and infected rats (n=10) are presented as mean ± 
standard deviation (SD). Student’s t-test was employed for statistical analysis and the 
levels of significance is indicated as ** p < 0.001.  
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3.2 UPEC invasion inside the testis 
To confirm that UPEC is able to reach the testis by ascending canalicular 
infection originating at the vas deferens, a number of techniques were applied to 
verify the presence of bacteria inside the testis, which include UPEC specific gene 
detection using PCR, streaking of testicular homogenate on agar plates to detect 
bacterial growth, fluorescent microscopy examination of infected tissues using an E. 
coli specific antibody and electron microscopical examination. The results of all 
named approaches demonstrated the presence of UPEC in testes on day 7 after 
bacterial injection (Figures 4~6). DNA isolated from testes was amplified by PCR to 
detect the gene expression of UPEC P pili. A specific band with the size of 328 bp on 
agarose gel was visible only in the samples of infected testes and the positive control 
(Figure 4A). Furthermore, streaking testicular homogenates on agar plates followed 
by overnight incubation revealed numerous yellowish-white translucent bacterial 
colonies exclusively in infected testes samples (Figure 4B).  
Moreover, fluorescent and electron microscopy were employed to further explore 
the localization of UPEC inside testis (Figures 5 and 6). Intriguingly, the bacteria 
labeled with anti-E. coli antibody were mainly observed in testicular compartment but 
rarely found inside the lumen of the seminiferous tubules (Figure 5). In agreement, 
electron microscopy examination also confirmed the presence of E. coli inside the 
interstitial space of infected testis (Figure 6).  
 
Figure 4 Presence of UPEC inside testes of infected rats on day 7 after 
bacterial injection in the vas deferens. (A) The genomic DNA was extracted from 
testicular tissue and 200 ng DNA from each sample were amplified with PCR using 
UPEC P pili primers. DNA isolated from one testis with direct UPEC injection served 
as a positive control. The PCR products were separated on 1.5% agarose gel and 
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stained with ethidium bromide. The same amount of DNA from each sample without 
PCR amplification was subjected to agarose gel electrophoresis and served as a 
loading control. Lane 1: 100 bp DNA marker (Promega, Mannheim); Lane 2~4: 
samples from saline injected animals; Lane 5~7: samples from UPEC infected rats; 
Lane 8: positive control; Lane 9: negative control. (B) Testes from saline injected (left 
panel) and UPEC infected rats (right panel) were homogenized in PBS, the 
homogenate were subsequently streaked on agar plates without antibiotics and kept at 
37°C. After overnight incubation colonies were counted under translucent light.  
 
Figure 5 Fluorescent microscopy examination reveals the location of UPEC in 
infected testis. Cryosections of testes from control (left panel) and UPEC infected 
rats (right panel) were incubated with anti-E. coli antibody overnight and then stained 
with secondary anti-rabbit IgG antibody conjugated to Cy-3 (Orange). The nuclei 
were counterstained with DAPI (Blue). Images were captured using fluorescent 
microscope Axioplan 2 Imaging system at original magnification X200. 
 
Figure 6 Presence of UPEC in the interstitium of infected testis. A semithin 
section of infected testis shows a part of seminiferous tubule (asterix) with the 
adjacent interstitial compartment. A bacterium is pointed with an arrow in the black 
frame; primary magnification X200. Inset: Electron microscopic examination on an 
ultrathin section shows the same bacterium in the identical area framed on the 
semithin section; primary magnification X3000. 
RESULTS 
‐ 57 ‐ 
 
3.3 The integrity of BTB and BEB in UPEC infected rats 
The results above (Figure 5 and 6) suggest that UPEC are able to migrate through 
the seminiferous tubules and reach the interstitial space of testis within 7 days. To 
explore whether UPEC crossed the tubular epithelium by disrupting the junctional 
structures in the testis (BTB) and epididymis (BEB), ultrathin sections from infected 
testes (Figure 7A) and epididymides (Figure 7B) were examined with electron 
microscopy. Surprisingly, the integrity of both junctional complexes was not affected 
by UPEC invasion, as indicated by the lanthanum tracer application which did not 
pass beyond the tight junctions of BTB and BEB after perfusion. These results 
suggest that UPEC may employ other invasion strategies than permanently 
compromising the integrity of BTB and BEB, although the exact mechanism remains 
elusive. 
 
 
Figure 7 Electron microscopical examination of the blood-testis barrier (BTB) 
and blood-epididymis barrier (BEB). (A) Ultrathin tissue section from a UPEC 
infected testis shows the tracer penetration within the seminiferous epithelium at 
X3000 magnification. Inset is the identical area of the black frame at X20000 
magnification showing that tracer penetration stopped at BTB tight junctions (arrow). 
(B) Ultrathin section from a UPEC infected epididymis demonstrates tracer 
penetration at epididymal epithelium at X3000 magnification. Inset indicates a BEB 
junctional complex consisting of a desmosome (arrow) and tight junctions (arrowhead) 
in the identical area represented in the black frame at X20000 magnification.  
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3.4 Histological changes in the testis following UPEC infection  
To investigate the impairment caused by UPEC infection, Hematoxylin & Eosin 
(H&E) stained sections from testes and epididymides were evaluated using light 
microscopy. The sections of cauda (Figure 8A, left panel) and caput epididymis 
(Figure 8B, left panel) from saline injected rats show a normal appearance of the 
tubular epithelium and interstitium with lumens full of spermatozoa. In striking 
contrast, severe interstitial fibrosis, inflammatory cell infiltration and numerous 
immature germ cells present inside the lumen were observed in infected cauda 
epididymis close to the site of bacterial injection (Figure 8A, right panel). Immature 
germ cells sloughed from testis into the lumens of caput epididymis indicates a 
detrimental effect of UPEC on spermatogenesis (Figure 8B, right panel). 
Histopathological examination revealed that spermatogenesis was affected to different 
degrees in neighboring seminiferous epithelium in UPEC infected testis, while it was 
completely normal in saline injected control animals (Figure 9). In sections from 
infected testes, 42.5% of seminiferous tubules were not affected; in 19.0% of tubules 
spermatogenesis proceeded up to elongated spermatid without spermatozoa; in 10.1% 
of tubules germ cells developed until round spermatid; 20.9% of tubules present 
spermatogenesis ceased at the stage of spermatocyte; whilst in the remaining tubules 
(about 7.5%) there were only a few spermatogonia and SC present in germinal 
epithelium, without any other stages of germ cells (Figure 9, right panel).  
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Figure 8 Histological changes in the cauda (A) and caput (B) epididymis. 
Tissue sections of paraffin embedded epididymides were stained with hematoxylin 
and eosin. Histopathological images were captured using Axioplan 2 Imaging system 
at magnification X200. Representative results from control (n = 5) and infected (n = 9) 
rats are shown.  
 
Figure 9 Histological changes in the testis on day 7 post injection. Tissue 
sections of paraffin embedded testes were stained with hematoxylin and eosin. 
Histopathological assessment was performed on control (n = 5) and UPEC infected (n 
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= 9) testes using light microscopy. The images were captured using Axioplan 2 
Imaging system at magnification X200 and representative figures are shown. An 
affected seminiferous tubule with arrest of spermatogenesis at the stage of primary 
spermatocyte is labeled with a pentacle; a tubule with multinucleated germ cells is 
labeled with a triangle.  
3.5 Sperm concentration on day 7 post infection 
Consistent with the results of the histopathological analysis demonstrating germ 
cell loss in infected testes, the concentration of spermatozoa retrieved from the cauda 
epididymis was found to be significantly decreased on day 7 after infection (Figure 10) 
compared to control rats (100.2 ± 56.8 × 106 vs. 249.8 ± 111.6 × 106/g tissue, p < 
0.05).  
 
Figure 10 The concentration of sperm retrieved from the cauda epididymis. 
Sperm concentration was assessed in seven animals of each group and the results are 
presented as mean ± SD. Statistical analysis was performed with Student’s t-test and 
statistical significance is denoted as * p < 0.05.  
3.6 DNA damage in germ cells caused by UPEC infection 
Since apoptosis is the dominating mechanism in regulating germ cell death under 
normal conditions, it was initially explored whether apoptosis was implicated in 
UPEC induced impairment of spermatogenesis and germ cell loss in 
epididymo-orchitis model. Therefore, TUNEL assay was carried out to detect DNA 
damage of testicular cells. The results (Figure 11) indicate that the number of TUNEL 
positive cells increased more than 20 folds in infected testes compared to controls 
(8.05 ± 2.99/tubule vs. 0.34 ± 0.07/tubule, p = 0.001). Moreover, the typical ring type 
chromatin aggregation under the nuclear membrane (early stage of apoptosis-like 
nuclei) [196] was also observed in some TUNEL positive cells (Figure 11, arrows). Of 
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note, there were a few TUNEL positive cells that lack the typical apoptotic ring-like 
nuclear structure, which might suggest that they were either at a different stage of 
apoptosis or undergoing necrosis. Strikingly, the majority of the TUNEL positive cells 
located within the seminiferous epithelium appeared to be germ cells.  
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Figure 11 TUNEL assay on cryosections of testes. (A) DNA strand breakage in 
testicular cells from control (upper panel) and UPEC infected (lower panel) rats were 
labeled with digoxigenin-nucleiotide and subsequently stained with 
anti-digoxigenin-fluorescein conjugated antibody (Green). The nuclei were 
counterstained with DAPI (Blue). The results were evaluated using Axioplan 2 
Imaging system and photographed at X200 magnification. The TUNEL (+) cells with 
ring-like nuclei are indicated with arrows. (B) The numbers of TUNEL (+) cells are 
presented as mean ± SD/seminiferous tubule. Student’s t-test was used for statistic 
analysis and the level of significance is indicated as ** p < 0.01.  
3.7 Expression pattern of apoptosis related genes in the testis 
As the TUNEL assay indicates that UPEC can cause DNA damage in testicular 
cells, it was next sought to delineate the specific mechanisms implicated in UPEC 
infection induced cell death in testis. Firstly, the expression pattern of the bcl-2 family 
genes was examined by quantitative realtime-PCR. The results (Figure 12) showed 
that bcl-2, an anti-apoptotic gene, was about two times upregulated in the testis on day 
7 post infection (relative expression in Ctrl v. s. Infected testis: 0.0039 v. s. 0.0090, p 
= 0.037). However, except a slight upregulation of bid mRNA level was observed in 
infected testes (relative expression in Ctrl v. s. Infected testis: 0.0080 v. s. 0.0116, p = 
0.037), no changes were found in bax (relative expression in Ctrl v. s. Infected testis: 
0.0198 v. s. 0.0223, p = 0.552) and bim (relative expression in Ctrl v. s. Infected testis: 
0.0309 v. s. 0.0252, p = 0.078) these two pro-apoptotic genes. The RNA level of 
another pro-apoptotic gene bak was even mildly down regulated (relative expression 
in Ctrl v. s. Infected testis: 0.0071 v. s. 0.0031, p = 0.025).  
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Figure 12 RNA expression pattern of the bcl-2 family genes in the testis. The 
expression of the anti-apoptotic gene bcl-2 (A), pro-apoptotic genes bax (B), bid (C), 
bim (D) and bak (E) in the testis were determined with quantitative realtime PCR. 
Target genes expression levels were normalized with the endogenous control 
ß-2-microglobulin (ß2M). Data are present as 2ΔCt, ΔCt=Cttarget gene-Ctß2M. The 
Mann-Whitney U test was employed for statistical analysis (* p < 0.05). Each single 
symbol (circle and triangle) represents one individual testis sample.   
3.8 Caspase activation in UPEC infected testis 
Since caspase activation is a hallmark and essential step in apoptosis execution, 
the activation of these factors was next assayed in total testis by Western blotting. As 
a positive control, RAW 264.7 cells were treated with 50 µM sodium nitroprusside 
(SNP) for 8 h to induce apoptosis. Activation of the extrinsic pathway is usually 
indicated by the cleavage of caspase-8. Surprisingly, the precursor protein of 
caspase-8 remained at unchanged levels in all samples investigated, and no caspase-8 
cleavage products were detected, indicating that an activation of this initiator enzyme 
did not occur (Figure 13A). Subsequent observation showed no activation of executor 
caspases (caspase-3 and -6) (Figure 13B). Furthermore activation of caspase-1 (a key 
enzyme in the pyrotosis pathway) was not observed in infected testis either (Figure 
13C).  
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Figure 13 Detection of caspase activation in the testis. Total testis proteins (20µg) 
from four different animals in each group were separated on 15% SDS-PAGE 
polyacrylamide gels. The immunoblots were probed with anti-caspase-8 (A), 
anti-caspase-3 (B, upper panel), anti-caspase-6 (B, lower panel) and anti-caspase-1 
(C) antibodies and then conjugated with a goat anti-rabbit-HRP secondary antibody 
for chemiluminescence detection. RAW 264.7 cells treated with sodium nitroprusside 
(SNP) served as a positive control. (D) The intensity of target bands on the films was 
measured with the ImageJ software (http://rsbweb.nih.gov/ij/). Semi-quantitative 
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results are presented as mean ± SD and Student’s t-test was used for data analysis 
(Caspase-8, p = 0.875; Caspase-3, p = 0.686; Caspase-6, p = 0.486; Caspase-1, p = 
0.343).  
3.9 Electron microscopical examination of the seminiferous epithelium 
 With biochemical evidence supporting that apoptosis is not the predominant cell 
death mode in total testis upon UPEC challenge, electron microscopical examination 
was next employed to examine the morphological changes in testicular cells. Apart 
from a few apoptotic germ cells (not shown), typical necrotic changes (condensation 
of chromatin into small, irregular patches) in poorly defined nuclei were also evident 
in infected testes (Figure 14B, left panel). Of note, the vacuolization and 
accumulation of lipid droplets within the cytoplasm of SC was commonly observed, 
indicating damage elicited in these somatic cells (Figure 14B, right panel).  
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Figure 14 Electron microscopical examination on the germinal epithelium. (A) 
Ultrathin section from a control rat testis shows normal morphology of the 
seminiferous epithelium (X1100). (B) Representative electron microscopical pictures 
(X1100) of infected testes demonstrate germ cells with necrotic nuclei (arrows) as 
well as SC with cytoplasmic vacuolization (right panel, asterix) and large lipid 
droplets (right panel, arrowheads).  
3.10 The viability of SC and PTC after E. coli infection 
 Based on the electron microscopical observation, the mechanisms of UPEC 
induced testicular somatic cells death were further investigated. The viability of 
isolated SC and PTC following UPEC treatment was measured using the MTT assay 
(Figure 15). After 2 h of treatment, the viability of both UPEC CFT073 treated cell 
types decreased below 30% (SC: 27.63 ± 7.84%, p = 0.004; PTC: 13.99 ± 4.95%, p = 
0.004). Previous studies from our group suggests that the secreted pore-forming toxin 
α-hemolysin (HlyA) plays a main role in causing calcium influx and suppressing host 
immune responses against UPEC infection (Sudhanshu B et al. unpublished data). To 
verify the causative involvement of this virulence factor in the observed decrease of 
cell viability, E. coli strains with different HlyA expression patterns were used for 
comparison. The treatment with FOS 22, which is a non-pathogenic K12 E. coli 
mutant ectopically expressing HlyA, resulted in a comparable decrease of viability as 
the cells treated with UPEC CFT073 (SC: 22.47 ± 3.39%, p = 0.001; PTC: 11.11 ± 
6.16%, p = 0.002). UPEC 536, which harbors two hlyA genes, demonstrated a higher 
cytotoxic activity indicated by a lower cell viability (SC: 7.90 ± 2.31%, p = 0.000; 
PTC: 7.55 ± 6.04%, p = 0.001). Of note, UPEC 536 double mutant HDM, which does 
not express HlyA due to deletion of both hlyA genes, did not cause any cell death (SC: 
138.21 ± 19.15%, p = 0.075; PTC: 98.77 ± 0.43%, p = 0.562) similar to the results of 
non-pathogenic E. coli treatment (SC: 142.09 ± 18.02%, p = 0.056; PTC: 97.73 ± 
2.14%, p = 0.208). 
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Figures 15 HlyA (+) E. coli strains cause a decrease of the viability in Sertoli 
(SC) and peritubular cells (PTC) in comparison to strains lacking HlyA (+). SC 
(A) and PTC (B) were treated with UPEC CFT073, FOS22, NPEC, Hemolysin 
Double Mutant (HDM) and UPEC 536 (multiplicity of infection, MOI = 20) for 2 h. 
Viability of cells was subsequently determined with the MTT assay. The data of 
infected samples were correlated to untreated control, which was normalized to 100%. 
Values are presented as mean ± SD of triplicate experiments. Student’s t-test was used 
to analyzed the significance of difference between control and individual infected 
sample (** p < 0.01).  
3.11 Annexin V/PI assay in SC and PTC 
To identify the type of cell death mode, SC and PTC were infected with distinct 
E.coli strains for 90 min, and stained with FITC-Annexin V and propidium iodide (PI) 
for flow cytometry analysis. Compared to untreated control samples (early apoptotic 
SC: 8.23 ± 1.09%, PTC: 5.09 ± 1.62%; late apoptotic or necrotic SC: 0.8 ± 1.05%, 
PTC: 2.65 ± 2.35%), the results of FITC-Annexin V/PI staining demonstrated that the 
percentage of early apoptotic SC and PTC in UPEC CFT073 infected samples 
strongly increased to 51.26 ± 6.44% (Figure 16B) and 24.75 ± 2.04% (Figure 16D), 
respectively. Notably, the proportions of late apoptotic or necrotic SC (10.17 ± 9.12%, 
Figure 16B) and PTC (46.07 ± 7.82%, Figure 16D) also increased significantly. 
Similar patterns were found in samples treated with two other HlyA (+) E. coli strains, 
FOS 22 (early apoptotic SC: 42.80 ± 4.08%, PTC: 20.09 ± 8.09%; late apoptotic or 
necrotic SC: 16.21 ± 8.36%, PTC: 46.83 ± 9.70%) and UPEC 536 (early apoptotic SC: 
37.08 ± 2.95%, PTC: 15.52 ± 4.99%; late apoptotic or necrotic SC: 6.48 ± 5.44%, 
PTC: 45.49 ± 9.78%). In agreement with the results of MTT assay, no increase of 
either Annexin V (+) or PI (+) cell numbers was observed in NPEC (early apoptotic 
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SC: 12.67 ± 5.70%, PTC: 5.17 ± 2.64%; late apoptotic or necrotic SC: 1.62 ± 1.30%, 
PTC: 5.03 ± 0.96%) and HDM treated samples (early apoptotic SC: 8.93 ± 1.42%, 
PTC: 4.72 ± 2.61%; late apoptotic or necrotic SC: 1.00 ± 0.9%, PTC: 3.17 ± 1.24%).  
 
RESULTS 
‐ 69 ‐ 
 
 
Figure 16 HlyA (+) E. coli strains induce apoptosis as well as necrosis in Sertoli 
(A and B) and peritubular cells (C and D). FITC-Annexin V/PI staining in SC and 
PT were analyzed using flow cytometry following E.coli (MOI = 20) infection for 90 
min. Experiments were repeated three times and typical contour figures are 
demonstrated in panels (A) and (C). The triplicate results are presented as mean ± SD 
and the corresponding summary is shown in panel (B) and (D). 
3.12 Expression of bcl-2 gene family in SC and PTC 
 As demonstrated by Annexin V/PI assay, phosphoserine exposure (Annexin V 
positive only) was found in a considerable population of infected SC and PTC, which 
is widely accepted as a characteristic of early apoptosis. To further explore whether 
the intrinsic apoptotic pathway is implicated in UPEC CFT073 induced SC and PTC 
cell death, quantitative real-time PCR was employed to analyze the expression of 
apoptosis related genes. In UPEC infected SC (Figure 17A), a moderate upregulation 
of the anti-apoptotic gene bcl-2 was evident (1.78 fold, p = 0.037); whereas no 
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changes were observed in the investigated pro-apoptotic genes, with the exception of 
bim was found to be mildly down regulated (0.34 fold, p = 0.037). In contrast, in 
UPEC infected PTC (Figure 17B) bcl-2 was slightly down regulated (0.69 fold, p = 
0.037) and the pro-apoptotic genes bax and bim were mildly up regulated (2.08 and 
2.35 fold, p = 0.014 and 0.037, respectively).  
 
 
 
Figure 17 The expression of bcl-2 gene family in isolated Sertoli (SC) and 
peritubular cells (PTC). RNA was isolated from SC (A) and PTC (B) following 
challenge with UPEC strain CFT073 (MOI = 20) for 3 and 4 h, respectively. The 
expression of bcl-2 gene family was determined using quantitative realtime PCR. 
Target gene expression was normalized using ß-2-microglobulin (ß2M) as reference 
and data are presented as relative expression (RE): RE = 2ΔCt UPEC-ΔCt Ctrl, ΔCt = Cttarget 
gene-Ctß2M. Mann-Whitney U test was used for the statistical analysis (* p < 0.05). 
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3.13 Caspase activation in SC and PTC 
 Caspase activation is the hallmark and commitment point of apoptosis [197]. To 
finally examine the putative involvement of apoptosis pathways in UPEC inducing 
SC and PTC death, caspase activation was determined by Western blotting (Figure 18). 
Similar to the observation from total testis, neither precursor degradation nor cleaved 
forms of caspase-8, -3 and -6 were found in infected SC at any time point investigated. 
Intriguingly, in infected PTC the full length protein levels of all three caspases were 
decrease in a time dependent manner, whereas the activated forms remained 
undetectable. To verify whether the degradation of full length precursors is indicative 
for caspase activation, enzymatic activity of the executor caspase-3 was measured in 
PTC. Of note, the caspase-3 activity remained at very low levels in PTC during the 
course of infection, which emphasizes that caspases were not activated. Furthermore, 
activated cleavage of caspase-1 was observed by Western blotting in neither SC nor 
PTC.  
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Figure 18 Detection of caspases activation in UPEC infected Sertoli (SC) and 
peritubular cells (PTC). SC and PTC were infected with UPEC CFT073 strain (MOI 
= 20) for various times as indicated. For Western blotting analysis, 20 µg of proteins 
were separated on 15% SDS-PAGE and immunoblots were probed with 
anti-caspase-8 (A), -3 (B, upper panel), -6 (B, lower panel) and -1 (C) antibodies. 
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ß-actin served as a loading control. RAW 264.7 cells treated with 50 µM sodium 
nitroprusside (SNP) for 8 h served as a positive control. Only in the positive control 
the cleaved forms of caspase-8, -3 and -6 could be specifically detected using Western 
blotting. (D) For caspase-3 enzymatic activity measurement 3 × 106 PTC in each 
sample were lysed and 100 µg of protein was assessed with Caspase-3/CPP32 
Colorimetric Assay Kit. The optical density (OD) values were quantified using a 
spectrophotometer at a wavelength of 400 nm. Results are presented as mean ± SD. 
Each experiment was repeated three times.  
3.14 DNA degradation in the testis following UPEC infection 
A late event in cell death is genomic DNA degradation with characteristic 
patterns for diverse cell death modes. As an example, an orderly DNA fragmentation 
pattern is usually associated with caspase-dependent apoptosis. In apoptotic cells the 
activation of endonucleases results in oligonucleosomal DNA fragments (DNA ladder) 
with steps of about 180 base pair (bp), while DNA is cleaved into fragments of 
random size by nonspecific lysosomal nucleases in necrotic cells. To determine which 
cell death mode plays the predominant role in infected testis and more specifically in 
SC and PTC, genomic DNA was isolated for agarose gel electrophoresis following 
UPEC infection. Figure 19 shows that DNA laddering with approximately 180 bp 
fragmentation was visible only in RAW 264.7 cells treated with 5 µM H2O2 for 24 h 
(Figure 19A, lane 9; B, lane 6), which served as a positive control for apoptotic DNA 
laddering. In saline injected control rats, total testis DNA remained intact (Figure 19A, 
lane 2~4), whereas the DNA samples extracted from infected testes demonstrated a 
smear pattern (Figure 19A, lane 5~7) similar to the necrosis positive control (Figure 
19A, lane 10; B, lane 7), indicating unspecific DNA degradation. In isolated SC and 
PTC, the intensity of high molecular DNA was decreased after UPEC infection but a 
regular pattern of DNA fragmentation was not observed (Figure 19B, lane 3 and 10). 
Of note, a smear pattern of DNA degradation as shown in necrotic positive control 
was not found in infected SC and PTC, despite cell death already occurred at that time 
points.  
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Figure 19 Pattern of oligonucleosomal DNA fragmentation. Genomic DNA was 
extracted from testes, isolated Sertoli (SC) and peritubular cells (PTC), respectively. 
For gel electrophoretic analysis, 5 µg of DNA from each sample were separated on 
1.5% agarose gels and stained with ethidium bromide. (A) Lane 1: 1 kbp DNA ladder. 
Lane 2~4: DNA extracted from testes of control rats (n = 3). Lane 5~7: DNA samples 
extracted from testes of infected rats (n = 3). Lane 8: untreated RAW 264.7 cells. 
Lane 9: RAW 264.7 cells were treated with 0.5 mM H2O2 for 24 h as a positive 
control for apoptosis. Lane 10: RAW 264.7 cells were frozen and thawed repeatedly 
as a positive control for accidental necrosis. (B) SC and PTC were infected with 
UPEC strain CFT073 (MOI = 20) for 4 and 6 h, respectively. Lane 1, 4 and 8: 1 kbp 
DNA ladder. Lane 2: untreated SC; Lane 3: infected SC; Lane 5~7: untreated, 
apoptotic and necrotic RAW 264.7 cells; Lane 9: untreated PTC; Lane 10: infected 
PTC.  
 
3.15 AIF nuclear translocation in UPEC infected SC  
 As the caspase-dependent pathway was found not to be activated in total testis 
and isolated SC and PTC upon UPEC infection (Figures 18 and 19), it was next 
investigated whether SC and PTC died by caspase-independent pathways. The 
intracellular localization of AIF, a well-characterized caspase-independent cell death 
effector, was examined in SC and PTC with confocal microscopy. In contrast to 
untreated and NPEC infected cells, AIF nuclear translocation was observed in UPEC 
treated SC at the indicated time points (Figure 20A). Moreover, similar results were 
evident in FOS 22 infected SC, which suggests that only the HlyA (+) E. coli strains 
RESULTS 
‐ 75 ‐ 
 
are able to induce AIF nuclear translocation in SC. However, AIF redistribution seems 
specific for SC as in infected PTC this protein was retained in the cytoplasm (Figure 
20B).  
 
Figure 20 Localization of apoptosis inducing factor (AIF) in Sertoli (SC) and 
peritubular cells (PTC). SC (A) and PTC (B) were treated with UPEC CFT073, 
FOS22 and NPEC (MOI = 20) for the indicated time points, and subsequently probed 
with rabbit anti-AIF antibody. AIF was labeled with Cy-3 conjugated anti-rabbit IgG 
secondary antibody (red) and the nuclei were counterstained with Cy5-conjugated 
To-Pro-3 (blue). The samples were analyzed with confocal microscopy. Scale bar: 30 
µm. Representative figures from triplicate experiments are shown. 
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3.16 Nuclear structure changes in UPEC infected SC and PTC  
 Once AIF translocates from mitochondria to the nucleus, it binds to DNA and 
triggers chromatinolysis and apoptosis-like chromatin condensation [198]. To analyze 
putative nuclear changes, nuclei stained with the cell-permeable DNA dye Hoechst 
33342 were evaluated using fluorescence microscopy following UPEC treatment. 
Notably, partial chromatin condensation and transparent nuclei were observed in SC 
after 1 h of UPEC treatment. The changes of nuclear structure became more 
prominent with an advanced pattern of peripheral chromatin condensation in the 
majority of SC following infection for 2 h (Figure 21A). In contrast to SC, 
progressing changes in nuclei with shrinking size and homogeneous chromatin 
condensation were evident in infected PTC in the first two hours (Figure 21B), which 
were indicative of necrosis [149,199]. Of note, SC and PTC display a similar pattern 
of nuclear pyknosis after 4 h of UPEC infection.  
3.17 Calpain activation in UPEC infected PTC   
 Previous studies from our group have proven that the UPEC pore-forming 
virulence factor HlyA is able to induce a rapid calcium influx in testicular and 
peritoneal macrophages (Sudhanshu Bhushan, et al. unpublished data). Calpain, a 
family of calcium dependent proteinases, can be activated by increased intracellular 
calcium and act as a key mediator implicated in AIF redistribution and programmed 
cell death [200]. Based on our observations, we speculated if calpain activation may 
play a role in UPEC induced SC and PTC death. Therefore, SC and PTC were 
pretreated with fluorogenic calpain substrate (CMAC, t-Boc-Leu-Met) followed with 
UPEC CFT073 infection up to 1 h. A strongly increased emission of blue fluorescence 
indicating calpain activation was observed only in PTC after 30 min of UPEC 
treatment (Figure 22). Surprisingly, there was no detectable fluorescence emitted from 
SC within 1 h of UPEC treatment (data not shown).   
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Figure 21 Influence of UPEC infection on nuclear structure in Sertoli (SC) and 
peritubular cells (PTC). SC (A) and PTC (B) were treated with UPEC CFT073 
(MOI = 20) for the indicated time points. Nuclei of these cells stained with Hoechst 
33342 were evaluated using fluorescence microscopy. Images were taken with the 
Axioplan 2 Imaging system at X1000 magnification. Results are representative of at 
least 80% cells/field observed in three independent experiments.  
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Figure 22 Calpain activation in UPEC infected PTC. PTC pretreated with 
fluorogenic calpain substrate (CMAC, t-Boc-Leu-Met) were subsequently infected 
with UPEC CFT073 (MOI = 20) for 30 min. Images were taken with the Axioplan 2 
Imaging system at X1000 magnification. Representative pictures were selected from 
three independent experiments with similar findings. 
 
3.18 Excessive ROS production in UPEC infected PTC 
 Overproduction of intracellular reactive oxygen species (ROS) as a major 
consequence of mitochondrial dysfunction is established to be strongly implicated in 
detrimental responses of host cells or tissues during microbial infection [201]. The 
MTT assay suggests that mitochondrial function is disrupted in SC and PTC during 
UPEC infection. Hence production of ROS in infected SC and PTC was examined 
using the oxidation sensitive fluorogenic probe 2’, 7’dichlorofluorescindiacetate 
(H2DCFDA). Intriguingly, UPEC treatment did not trigger any increase of ROS in SC 
within one hour (Figure 23A and C). In contrast to this observation in SC, a surge of 
ROS production was seen in PTC after 30 min of UPEC stimulation which gradually 
returned back to basal level in about 90 min (Figure 23B and D). However, NPEC 
treatment did not cause significant changes of ROS production in SC or PTC.  
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Figure 23 Intracellular reactive oxygen species (ROS) production in Sertoli 
(SC) and peritubular cells (PTC). SC and PTC were pretreated with H2DCFDA for 
30 min and ROS levels were assessed with flow cytometry following E.coli treatment. 
The fluorescence intensity of infected samples was referred to the basal level of 
untreated control, which was normalized as 100%. The representative histograms 
from untreated and UPEC infected samples are shown in panel (A) and (B). The data 
points represent mean ± SD of three independent experiments and shown in panel (C) 
and (D). Student’s t-test was used for statistical analysis. (**) indicates p<0.01 
compared to the untreated control. 
3.19 ATP depletion in UPEC infected SC and PTC 
 The intracellular ATP level is an important switch to determine cell fate between 
apoptosis and necrosis [202]. Apoptosis is an active process requiring ATP for 
execution, e.g., for caspase activation, chromatin condensation and nuclear 
fragmentation [178]. Therefore, ATP levels in apoptotic cells are maintained at normal 
level until the very end of the cascade [203]. In contrast, necrosis can be continued 
even ATP storage is deleted. To determine whether UPEC can cause energy failure in 
infected SC and PTC, ATP levels were analyzed by the luciferin-luciferase assay 
following bacterial treatment. In SC, the intracellular ATP level started to decline after 
1 h of UPEC treatment and rapidly decreased to lower than 10% within 2 h (Figure 
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24A). Similarly, the ATP level in infected PTC declined in a time dependent manner 
and gradually decreased to below 20% of normal levels within 4 h of UPEC treatment 
(Figure 24B).  
 
 
 
Figure 24 UPEC infection caused intracellular ATP depletion in Sertoli (A) and 
peritubular cells (B). ATP levels were quantified by the luciferin-luciferase assay 
following UPEC treatment for the indicated time points. The results were normalized 
to untreated control samples and are presented as relative percentages. The bars 
represent the mean ± SD of duplicate experiments. Student’s t-test was employed for 
statistical analysis. (*) represents p < 0.05 compared to the untreated samples.    
 
3.20 HMGB1 release in testicular cells after UPEC infection 
Previous studies confirmed that high-mobility group box 1 (HMGB1), a nuclear 
factor and a secreted protein, can be a maker of necrosis as it is passively released into 
the cytoplasm of necrotic or damaged cell whilst it retains in the nucleus of healthy 
and apoptotic cell [166]. As indicated by the results above, necrosis likely occurred in 
SC and PTC after UPEC infection. To further determine the predominant cell death 
mode in UPEC treated SC and PTC, the subcellular localization of HMGB1 was 
investigated using immunofluorescent microscopy. Although the protein level of 
HMGB1 in total testis was not affected by UPEC infection (Figure 25A and B), 
different patterns of HMGB1 subcellular localization were observed between infected 
and control testes. In agreement with previous observations [204], mainly testicular 
somatic cells were probed with Cy3 conjugated anti-HMGB1 antibody. In control 
testes, HMGB1 was exclusively found in the nuclei of somatic cells, i.e., SC (arrows), 
PTC (arrow heads), and some other interstitial cells (Figure 25C, left column). In 
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contrast, a predominant cytoplasmic distribution of HMGB1 was observed in somatic 
cells of infected testes (Figure 25C, right column).  
In agreement with the in vivo results, HMGB1 translocation from the nuclei to 
cytoplasm was verified in vitro using isolated SC and PTC which were treated with 
UPEC CFT073 and FOS 22 (Figure 26 A and B). In contrast, HMGB1 retained in the 
nuclei of NPEC infected and untreated SC. Consistent with the in vivo observation, a 
small proportion of HMGB1 was also detected in the cytoplasm of untreated PTC 
(Figure 26B). 
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Figure 25 HMGB1 expression and localization in the testis. (A) For Western 
blotting analysis, 20 µg of protein extracted from total testis of control (n = 4) and 
infected (n = 4) rats was separated on a 12.5% SDS-PAGE. HMGB1 was detected by 
immunoblot using anti-HMGB1 polyclonal antibody and goat anti-rabbit HRP 
conjugated secondary antibody. ß-actin served as a loading control. (B) The intensity 
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of target bands was measured with the ImageJ software. The data are presented as the 
relative intensity = intensity of HMGB1/intensity of ß-actin. (C) Testis cryosections 
were probed with Cy-3 conjugated rabbit anti-HMGB1 and nuclei were 
counterstained with DAPI. Images were photographed using the Axioplan 2 Imaging 
system at X400 magnification. In control samples (left column), some Sertoli and 
peritubular cells were indicated by arrows and arrow heads, respectively.  
 
Figure 26 The subcellular HMGB1 localization in isolated Sertoli (A) and 
peritubular cells (B). HMGB1 was probed with rabbit anti-HMGB1 antibody and 
Cy-3 conjugated secondary antibody following challenge of the indicated E. coli 
strains for 2 h. The subcellular location of HMGB1 was determined with normal 
fluorescence microscopy (A, X1000 magnification) and confocal microscopy (B, 
scale bar: 30µM). Representative results of triplicate experiments are shown.  
3.21 NF-ĸB signaling pathway in the testis upon UPEC infection  
 The NF-ĸB (nuclear factor kappa-light-chain-enhancer of activated B cells) 
signaling pathway plays a pivotal role in innate immune response upon infection. 
Activation of the NF-ĸB pathway is also associated with the secretion of the 
proinflammatory protein HMGB1 from the nucleus of activated macrophage [165]. 
Therefore, it was next to investigate if the NF-ĸB pathway is implicated in host 
response against UPEC infection and the observed HMGB1 release in testicular cells. 
The activation of NF-ĸB is essentially initiated by the degradation of its inhibitor 
IkBα (nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, 
alpha). Seven days after UPEC infection, the level of IkBα protein expression was 
found to be comparable between UPEC infected and control testes (Figure 27A and 
B). In agreement, the p65 subunit of NF-ĸB retained in the cytoplasm in all samples 
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(Figure 27C). Similar observations were found in rats after one day and three days of 
infection (data not shown), indicating that the NF-ĸB pathway is not involved in 
UPEC infection of the testis.    
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Figure 27 NF-ĸB pathway in UPEC infected testis. (A) Total testis proteins were 
separated on 10% SDS-PAGE. Immunoblots were labeled with mouse anti-IkBα 
antibody. ß-actin served as a loading control. (B) The intensity of target bands was 
measured with the ImageJ software. The results are presented as the relative intensity 
= intensity of p65/intensity of ß-actin. (C) Testis cryosections were probed with Cy-3 
conjugated mouse anti-p65 and the nuclei were counterstained with DAPI. Images 
were captured using Axioplan 2 Imaging system at X400 magnification. 
Representative results from at least two independent experiments are shown.  
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4 DISCUSSION  
4.1 The establishment of a UPEC induced epididymo-orchitis model 
 Infection and inflammation of the male urogenital tract is widely acknowledged 
as an important aetiological factor of infertility [79]. Anatomically, the testis, the 
excurrent duct system and accessory glands are all connected to the urethra, providing 
a potential gateway for the retrograde microbial infections [1]. Acute epididymitis 
secondary to retrograde UTIs spreading via the vas deferens can potentially affect the 
testis and manifest as epididymo-orchitis [1]. Microbial infections of the epididymis 
and testis may lead to direct exposure of gametes and germinal epithelium to invading 
pathogens and inflammatory products, thus ultimately resulting in reduced fertility 
[205]. E. coli is the most frequently isolated pathogen from semen samples of infertile 
men as well as patients with prostatitis and epididymitis [91,92,97]. Although the 
particular E. coli strain accounting for reduced fertility has yet to be identified, it is 
speculated that UPEC, a primary causative pathogen of UTIs, is most likely 
responsible for E. coli induced epididymo-orchitis [98,206]. This is supported by the 
recent observation that more than 50% of E. coli samples obtained from patients with 
epididymitis have hemolytic activity as is characterized for UPEC (Clinic of Urology, 
Giessen, personal communication). Therefore, in this study, the UPEC strain CFT073 
was employed as it was assumed to be clinical relevant and its full genome has been 
sequenced. Studies conducted in the past outlined the deleterious effects of pathogenic 
E. coli on human spermatozoa [83,207]. These in vitro investigations observed that 
high concentrations of pathogenic E. coli can cause a decrease of motility and mediate 
morphological alterations in sperm. A latest study further revealed sperm 
immobilization factor isolated from E. coli can induce receptor-dependent 
immobilization of sperm [208]. However, thus far the interactions between pathogenic 
E. coli and host cells in the testis have yet to be elucidated. Therefore, the aim of my 
PhD project was to investigate the impairment of spermatogenesis in UPEC induced 
epididymo-orchitis, as well as to characterize the responses of the testicular cells in 
the seminiferous epithelium upon infection.  
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 The investigation of the pathogenesis of bacteria induced epididymo-orchitis has 
been facilitated by the development of in vivo animal models. Previously, E. coli 
induced epididymo-orchitis models have been generated by directly injecting bacteria 
into the testis or vas deferens [190,192]. It has been shown that unilateral bacterial 
injection into vas deferens is able to elicit an inflammatory response and cause 
damage to both the ipsilateral and contralateral epididymides as well as the testes 
[192]. In this study, UPEC were bilaterally injected into the vasa deferentia of the rat 
to induce epididymo-orchitis. The effect of UPEC infection on the testis was 
investigated on day 7 post infection to allow UPEC to reach the testis. In addition, 
preliminary studies performed in our group did not find significant changes in the 
testis at earlier time points (on days 1 and 3, data not shown). Importantly, inflamed 
epididymides and testes were observed on day 7 post infection, as indicated by gross 
morphological changes of these organs (Figure 3A). Furthermore, reduced testicular 
size and weight was evident in infected rats compared to control animals (Figure 3B), 
which is indicative of degenerative changes within the testis.  
In addition to the inflamed appearance observed in the epididymides and testes of 
infected rats (Figure 3A), the presence of UPEC within the testes was also confirmed 
by PCR and bacterial colony formation (Figure 4). Critically, for the first time my 
investigation revealed UPEC localized within the testis of an epididymo-orchitis 
model. A recent study reported that E.coli injected into the interstitial space of the 
testis were eradicated by host immune responses within four days [190]. In contrast, 
bacteria injected into the seminiferous tubules still could be detected until 56 days 
post infection. These findings suggest that the level of immune response in the 
interstitium of the testis is much more robust than in the seminiferous epithelium. 
Intriguingly, in this study E. coli were predominantly found in the interstitial 
compartment of the testis on day 7 following UPEC infection (Figures 5 and 6), 
although bacteria face stronger immune response than in the lumen of seminiferous 
tubules. However, the mechanism of UPEC invasion through the germinal epithelium 
to interstitium of the testis remains unclear.  
Importantly, the concentration of UPEC employed in my study was much lower 
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than previously used in other in vitro investigations where human spermatozoa were 
infected [83,207]. Previous clinical reports have suggested that bacterial 
concentrations in semen of confirmed cases of bacterial prostatitis ranged from 103 
cfu/ml to more than 106 cfu/ml [189]. More recently a study employed similar 
amounts of E. coli (106 cfu) for microinjection into the seminiferous tubules to 
investigate spermatogenic disturbance in mouse [190]. These prior investigations have 
provided both clinical and experimental rationales for the concentration of bacteria 
used in my in vivo study.  
Overall my findings showed the successful establishment of an in vivo model 
mounting inflammatory responses in the testis and epididymis. Furthermore, the 
localization of UPEC inside the testis suggests infection can potentially cause 
structural damage to the testis which ultimately disturbs spermatogenesis.  
4.2 UPEC invasion does not compromise the integrity of the BTB and BEB 
 It is well acknowledged that the tight junction between adjacent SC (known as 
BTB) provides an anatomical separation between the adluminal compartment and the 
rest region of the testis [1]. Previous study has demonstrated that UPEC CFT073 can 
disrupt the tight junctions of murine renal inner medullary collecting duct cells thus 
facilitating bacterial dissemination into the renal interstitium [209]. Given my 
findings of bacterial localization within the interstitium of the testis, the impact of 
UPEC infection on the BTB was next investigated. The integrity of another tight 
junction in the epithelium of the epididymis (BEB) was also assessed. Intriguingly, 
electron microscopical examination revealed UPEC did not compromise the integrity 
of the BTB or BEB (Figure 7), albeit it was observed that bacteria were able to cross 
through the germinal epithelium. There are several likely explanations for these 
observations. Firstly, as UPEC can transiently invade and survive within epithelial 
cells of the urinary tract, these pathogens may probably internalize within SC and 
PTC, thus permitting invasion into the interstitium by directly passing through the 
cells in the seminiferous epithelium [210]. This assumption is further supported by a 
recent study demonstrating that TLR-4, which is also expressed in SC and PTC, 
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facilitates the passage of UPEC across renal collecting duct cell layers without 
altering the tight junctions [209]. On the other hand, it has been shown that the 
integrity of the BTB can be reversibly disrupted by TNF-α secreted from SC and 
germ cells [73]. In correlation, a significant upregulation of TNF-α at mRNA level 
was observed in UPEC infected testis in my in vivo model (Yongning L et al. 
unpublished data). This leads to another possibility that instead of permanently 
compromising the tight junctions, UPEC might temporarily affect the BTB by 
manipulating the expression of TNF-α or other mediators, which in turn facilitates 
bacterial invasion into the interstitium of the testis.  
In addition, it was previously reported that E. coli injected inside the seminiferous 
tubules could disrupt the inter-SC tight junctions at later stage [190]. However, the 
morphological and functional alternations of the compromised tight junctions were 
not described. As no functional disruption of the BTB was observed in my 
investigation, future studies would need to include a greater range of time points to 
gain a comprehensive evaluation. Dynamically monitoring the integrity alternation of 
the BTB during infection, and investigations on UPEC invasion in SC and PTC, may 
provide a deeper insight to the mechanism by which UPEC disseminate inside the 
testis.  
4.3 UPEC infection causes impairment of spermatogenesis 
Given UPEC were able to invade through the genital ducts and caused a decrease 
in testicular weight, histopathological evaluation of the epididymis and testis was 
performed using H&E stained tissue sections. In the cauda epididymides of UPEC 
infected rats, immune cell infiltration was evident in the interstitium (Figure 8A, right 
panel). This indicated an inflammatory response was elicited in the epididymis 
proximal to the site of UPEC injection. Notably, numerous immature germ cells were 
also found to be sloughed inside the lumen of the epididymis (Figure 8A and B, right 
panel). This suggests a disturbance of spermatogenesis within the testis. Indeed, the 
loss of germ cells and degeneration of the seminiferous epithelium was evident in 
different regions of the infected testes (Figure 9). Importantly, varying degrees of 
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spermatogenic impairment were observed in neighboring seminiferous tubules, for 
example, from partial depletion of spermatozoa to only a few spermatogonia remained. 
Similar regional differences within the same testis in respect to spermatogenic lesions 
are also commonly found in experimental autoimmune orchitis animal models and 
non-obstructive azoospermia patients [1,211]. This suggests that the detrimental effect, 
which was caused by UPEC infection in my study, does not apply evenly throughout 
the whole testis. Furthermore, a significant decrease of sperm concentration was 
observed following 7 days of infection in comparison to control rats (Figure 10). 
These results demonstrate a pro-inflammatory response evoked by UPEC and the 
damaging effect induced by ascending infection in the epididymis and testis, which 
may result in reduced fertility. Future investigations on the functional and structural 
abnormalities of sperm in this in vivo model may provide a greater insight into the 
impact of UPEC infection on fertility.  
Previous studies have described impairment of spermatogenesis in other E. coli 
induced orchitis models [190,192]. Nagaosa and colleagues have demonstrated a 
disturbance of spermatogenesis as early as day 1 by directly microinjecting E. coli 
into the seminiferous tubules in a mouse model [190]. Critically the majority of 
seminiferous tubules were found to be affected within 2 days. In contrast, severe 
impairment of spermatogenesis was found in my in vivo model by day 7 but not on 
days 1 and 3 post infection. These distinct observations may be due to different sites 
of bacterial injection. In comparison to direct injection into the seminiferous tubules, 
the disturbance of spermatogenesis may occur later if bacteria are injected into the vas 
deferens, as infection requires time to spread to the testis. In addition to germ cell loss 
and seminiferous epithelium lesions, Demir and colleagues also found mild interstitial 
fibrosis in the testis of their E. coli induced epididymo-orchitis model, which was not 
observed in my investigation [192]. This may be explained by the fact that in the 
previous study analysis of histological changes in the testis was conducted at a later 
time point (14 days), which may reflect the pathological lesions in an advanced stage. 
Of note, seminiferous epithelium could not recover from the disturbance caused by 
infection, even after the invading bacteria were eliminated either by host immune 
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responses or antibiotic treatment [190,192]. These findings suggest that the damaging 
effects caused by UPEC infection may not be limited to germ cells, but may also 
affect other somatic cells or even the whole testicular milieu. However, the underlying 
mechanism has yet to be elucidated.  
4.4 UPEC do not activate classical apoptosis pathways in the testis  
To obtain a comprehensive understanding of molecular mechanisms implicated in 
UPEC caused spermatogenic impairment, it was next to characterize possible cell 
death pathways involved in infected testis, specifically in investigated somatic cells 
(SC and PTC). Apoptosis has been found to be an important mechanism controlling 
germ cell populations in physiological conditions [212]. Moreover, apoptosis is also 
involved in urothelial cell death following UPEC infections [212,213]. Therefore, it 
was of great importance to investigate whether UPEC can induce apoptosis in the 
testis. TUNEL assay was initially employed to provide a quantitative examination of 
an apoptotic index in the testis. The result demonstrated a dramatic increase of 
TUNEL (+) testicular cells in infected rats in comparison to control animals (Figure 
11). This finding indicates that UPEC infection can induce DNA breakage in affected 
testicular cells, the majority of which are located in the seminiferous epithelium and 
appeared to be germ cells based on their position. However, previous studies have 
suggested that in some cases the breakage of DNA strand detected by TUNEL (+) 
staining are probably associated with necrotic cells as well [196,214]. To distinguish 
apoptosis from necrosis, several techniques were employed to further identify both 
biochemical and morphological characteristics of infected testis. Klumpp and 
colleagues reported that a UPEC isolate NU14 was able to induce caspase-dependent 
apoptosis in urothelial cells by activating both extrinsic and intrinsic apoptotic 
cascades [213]. In this study, the apoptosis pathways were evaluated by detecting the 
expression pattern of the bcl-2 gene family (Figure 12) and activation of caspase 
(Figure 13). However, all these findings indicate that UPEC infection does not 
activate the caspase-dependent pathway in the testis. This discrepancy may be 
explained by the finding of the TUNEL assay which illustrates that the amount of 
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cells with apoptotic nuclear feature was just a relative small proportion of total 
testicular cell population.  
Furthermore, in vitro investigation demonstrated a lethal effect of UPEC infection 
on SC and PTC, as illustrated by the significant decrease of cell viability (Figure 15) 
and disruption of plasma membrane (Figure 16). However, as shown by qRT-PCR 
(Figures 17) and Western blotting (Figure 18), there was no evidence to suggest the 
activation of caspase-dependent pathways in infected SC and PTC. This was further 
supported by the lack of oligonucleosomal DNA fragmentation in infected total testis 
and investigated somatic cells, which is a hallmark of classical caspases-dependent 
apoptosis (Figure 19). These findings provide additional evidence to exclude the 
involvement of classical apoptosis as a predominant death mode in UPEC infected 
testis.  
Apart from biochemical characterization, morphological evaluation can provide 
further indication of alternative modes of cell death. In previous investigations using 
epididymo-orchitis models, degeneration of the seminiferous epithelial cells was 
usually underscored based on H&E staining [190,192,194]. However, H&E staining 
based morphological assessment alone cannot provide sufficient information about 
the cellular alternations in various types of affected testicular cells. Therefore, 
electron microscopical examination was additionally employed in this study to 
evaluate the ultrastructural abnormalities of germ cells and somatic cells in UPEC 
infected testes. Interestingly, beside necrotic germ cells, electron microscopy revealed 
degeneration of SC in infected testis as indicated by severe cytoplasmic vacuolization 
and extensive lipid droplets accumulation (Figure 14B). Instead of apoptotic features, 
the cytoplasmic changes were observed in affected SC prior to DNA breakage. 
Similar ultrastructural abnormalities have been observed in several pathological 
conditions associated with impaired spermatogenesis [215,216]. It has been reported 
that the vacuolization in the cytoplasm of SC is due to swelling and coalescence of 
intracellular membrane bound organelles, particularly endoplasmic reticulum and 
vesicles [217,218]. Furthermore, the presence of extensive large lipid droplets in SC 
may be related to increased phagocytic activity following germ cell damage upon 
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UPEC infection, but may also indicate disturbance of lipid metabolism [216]. 
Importantly, these findings in damaged SC have not been described in any other in 
vivo epididymo-orchitis model to date. Considering the crucial role of SC in 
spermatogenesis maintenance, observation of the degenerative changes may provide a 
better understanding of the mechanism contributing to irreversible impairment of 
spermatogenesis in bacterial orchitis. However, future functional studies (such as 
inhibin B measurement) should be conducted to further evaluate the impact of UPEC 
infection on SC.  
Taken together, these results suggest that the majority of testicular cells respond 
differently from other cell types such as urothelial cells following UPEC infection, as 
the classical apoptotic pathways are not activated. Given these findings, alternative 
mechanisms other than caspase-dependent pathway must be involved in the cell death 
of SC and PTC. 
4.5 AIF mediates programmed cell death in UPEC infected SC   
 Caspase-dependent apoptosis has long been synonymous with programmed cell 
death (PCD), referring to a highly regulated form of cell suicide [219]. To date it is 
widely believed that even in absence of caspase activation, PCD can be achieved by 
different mechanisms [220,221]. For example, it was reported that in presence of 
pan-caspase inhibitor, the soluble O6-toxins of UPEC induced apoptosis in renal 
tubular cells in a caspase-independent manner [222]. Amongst all 
caspase-independent executioners in PCD, AIF is one of the best characterized thus 
far. In my study, AIF was found to relocate into the nuclei of SC following UPEC 
CFT073 or FOS 22 treatment (Figure 20A). In contrast, localization of AIF was found 
no change in PTC following infection (Figure 20B). This suggests that AIF is 
specifically involved in UPEC triggered SC death. Furthermore, it has been described 
that AIF mediated PCD shares some biochemical characteristics with classical 
caspase-dependent apoptosis such as phosphatidylserine externalization [148]. 
Impressively, the exposure of phosphatidylserine was also observed in the majority of 
SC following 90 min of infection using HlyA (+) strains (Figure 16A and B). It has 
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been established that exposure of phosphatidylserine can facilitate recognition and 
phagocytosis of dying cells, thus attenuating host immune responses elicited by cell 
death [223]. In addition, previous reports showed the release of AIF from the 
mitochondria could be triggered by calpain activation in a calcium-dependent fashion, 
or via PARP-1 and cathepsins activation independent of calcium [224]. However, in 
my investigations the putative activation of calpain was not observed in SC following 
UPEC infection. Therefore, further studies surrounding the activation of PARP-1 and 
cathepsin may help to gain deeper insight into the mechanism of AIF redistribution in 
UPEC infected SC. Additionally, previous findings have demonstrated that AIF is able 
to trigger peripheral chromatin condensation and subsequential apoptosis- or 
necrosis-like PCD depending on cell type and stimuli [148]. In agreement with 
previous reports, in my study a typical peripheral chromatin aggregation was evident 
only in SC at early stages of UPEC infection (approximately in 1~2 h), as assessed 
using Hoechst 33342 staining (Figure 21). Taken together, these results corroborate 
the specific involvement of AIF in UPEC induce SC death. Further studies on 
upstream signals triggering AIF release and the underlying mechanism involved in 
AIF induced DNA degradation may help to outline the AIF-dependent cascade 
implicated in UPEC induced SC death.    
4.6 UPEC induce programmed necrosis in PTC 
 In contrast to SC, UPEC infected PTC underwent a distinct mode of cell death 
without the participation of AIF. Based on observation with Annexin V/PI staining, 
rapid loss of membrane integrity was evident in nearly half of UPEC infected PTC 
(Figure 16C and D). This indicates necrosis may be a dominant mode of cell death in 
this specific cell type. Necrosis has often been described as an accidental and 
uncontrolled consequence of extreme physico-chemical stress. However, 
accumulating evidence emphasizes that certain forms of necrosis are tightly regulated 
and occur under certain conditions [225]. In accordance with previous investigations 
on programmed necrosis, a sequence of intracellular events implicated in UPEC 
induced PTC death was delineated in my study, with observations of calpain 
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activation, excessive ROS production, ATP depletion and nuclear pyknosis [169,176].  
The activation of calpain occurred very early in infected PTC following UPEC 
treatment (Figure 22). This is usually considered a consequence of Ca2+ influx and in 
turn contributes to a secondary intracellular Ca2+ spikes by abolishing the Na+/Ca2+ 
exchanger [226]. Although intracellular Ca2+ level has not been determined in my 
study, observed calpain activation is widely accepted as a key procedure inducing cell 
death by multiple mechanisms, including the facilitation of death effectors (e.g. AIF 
and Cytochrome C) release from mitochondria [227], cleaving of cytoskeleton 
components [226], and the induction of cathepsin release from lysosomes [160]. 
Therefore, activation of calpain appears to have contributed to UPEC induced PTC 
death.  
Furthermore, a rapid and transient burst of ROS level was also observed in UPEC 
infected PTC (Figure 23C and D). Increased oxidative stress usually occurs during 
microbial infection. Some clinical and experimental in vivo investigations have 
revealed that excessive ROS can be generated by spermatozoa and semen neutrophils 
in epididymitis [228,229]. Interestingly, Kaya and colleagues reported that an 
oxidative stress status also occurred in the testis of UPEC induced epididymitis in rat 
without neutrophil accumulation [230]. As indicated by excessive ROS generation, 
the balance between free radicals and scavengers must be disturbed and mitochondria 
may be affected in PTC following UPEC infection. The excessive production of ROS, 
acting as another cell death mediator, in turn leads to permeabilization of 
mitochondrial membranes [231], DNA damage [232], lipid oxidation [233] and 
subsequential cellular membrane disruption [159]. Interestingly, excessive ROS 
generation was not observed in infected SC (Figure 23A and B). A likely reason is the 
cytosolic ROS may be neutralized by AIF, which was released from the mitochondria 
of UPEC infected SC and could also act as peroxide scavenger.  
Importantly, evidence in favor of SC and PTC undergoing necrosis is the 
observed decline of intracellular ATP level during UPEC treatment (Figure 24). It is 
widely accepted that ATP depletion is an initiator of necrosis, as the apoptotic 
machinery is hindered by energy failure in contrast to necrotic cell death which is 
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ATP-independent [202]. Earlier studies in different models were conducted to 
determine the threshold of ATP level before internal machinery switches the modality 
of cell death from apoptosis to necrosis. Although the results varied between cell 
types and lethal insults, it is widely accepted that once ATP declines below 15~25% of 
normal level, necrotic cell death is irretrievable [234,235]. In my study, ATP levels 
decreased below such thresholds in SC after 2 h and in PTC after 4 h of UPEC 
infection (Figure 24). Notably, in the initial stages of infection (1~2 h), the majority of 
SC demonstrated AIF nuclear translocation (Figure 20) and peripheral chromatin 
condensation (Figure 21), whilst did not display plasma membrane rupture (Figure 
16). As the UPEC infection continued, similar nuclear condensation as infected PTC 
(Figure 21) and ATP depletion (Figure 24) was observed in SC. Based on nuclear 
features and the integrity of plasma membrane, AIF mediated cell death can be 
categorized into apoptosis- and necrosis-like PCD [126,148]. It is assumed that the 
declining ATP levels contributed to the switch of AIF mediated apoptosis-like to 
necrosis-like PCD in UPEC infected SC. 
All these modulators investigated in this study are well known players in cell 
death irrespective of the stimuli. Taken alone neither calpain nor ROS is specific for 
necrosis, but different mediators participate simultaneously in an organized 
self-destruction cascade may define programmed necrosis [169]. Distinct cell death 
cascades were found to be implicated in UPEC infected SC and PTC. Indeed, even 
facing to a given death stimulus, the involved modulators and cascades can be cell 
type specific.  
4.7 HlyA is a candidate virulence factor for induction of SC and PTC death 
 Given the lethal effect on SC and PTC, it is of great importance to determine the 
major virulence factors involved in UPEC induced PCD. Lipopolysaccharide (LPS) is 
one of the best characterized virulence factors of E. coli in multiple experimental 
systems. Previous investigations have described impaired spermatogenesis in acute 
inflammation animal models induced by intraperitoneal LPS injection [236,237]. In 
contrast, Nagaosa and colleagues found that neither dead E. coli nor LPS injected into 
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the seminiferous tubules could induce a detrimental effect on spermatogenesis [190]. 
These conflicting observations indicate distinct mechanisms may be involved in 
different infection models. Systemic and local inflammatory responses can be 
mounted by intraperitoneal LPS injection that subsequently affects testicular function 
[32,45]. However, the immune response evoked by dead bacteria or LPS within the 
seminiferous tubules appears to play little role in spermatogenic impairment when the 
germinal epithelium is directly exposed to E. coli. In agreement with the observations 
of Nagaosa and colleagues, my findings showed that the NPEC 470 strain expressing 
LPS did not decrease viability in SC and PTC (Figure 15). Therefore, other virulence 
factors produced by living UPEC such as secreted soluble toxins are assumed to 
contribute to the death of infected testicular cells. Another study on a pore-forming 
toxin described a series of cell death cascades which is similar to my observations in 
UPEC infected SC and PTC [176]. As an important virulence factor thoroughly 
characterized, an E. coli pore-forming toxin HlyA is able to induce Ca2+ influx and 
manipulate cell death in various target cells [238]. By employing various E. coli 
strains, it was revealed that only those strains with HlyA encoding sequence were able 
to induce SC and PTC death (Figure 15). Furthermore, HlyA (+) E. coli strains caused 
phosphatidylserine exposure and plasma membrane disintegration in infected SC and 
PTC (Figure 16). Therefore, HlyA appears to be a primary candidate contributing to 
the pathogenesis of UPEC infection causing damage within the testis and inducing 
programmed necrosis in SC and PTC. Future studies need to investigate if blocking 
the binding of HlyA to cell membrane can abolish the lethal effect of UPEC on target 
cells.  
4.8 UPEC induce SC and PTC death with inflammatory consequence 
 Although it is increasingly acknowledged that necrosis and apoptosis demonstrate 
more morphological and biochemical similarities than initially thought, making a 
distinction between the different modes of cell death is still necessary, particularly 
considering that necrosis is usually associated with inflammatory responses. The 
rupture of the plasma membrane in necrotic cells allows intracellular contents to be 
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spilled into extracellular milieu to elicit an immune response. HMGB1 belongs to the 
damage-associated molecular pattern (DAMP) molecules released from necrotic cells 
[239]. Previous investigations reported an upregulation of HMGB1 in the testis in a 
LPS-induced acute inflammation model, indicating that the testis was under stress 
[237]. However, in this study the expression of HMGB1 remained unchanged whilst 
this protein was released from the nuclei in UPEC infected testis (Figures 25). 
Furthermore, HMGB1 redistribution to the cytoplasm was also observed in both SC 
and PTC following infection with HlyA (+) E. coli strains (Figure 26). It has been 
reported that active secretion of HMGB1 can be triggered by the activation of NFĸB 
pathway in macrophages [165]. However, in infected testis, the release of HMGB1 
was not associated with the NFĸB pathway as UPEC infection did not trigger IkBα 
degradation and p65 nuclear translocation in testis (Figure 27). These results favor 
necrotic injury in testicular cells, as apoptotic cells firmly retain HMGB1 within 
nuclei even after undergoing secondary necrosis and autolysis [166]. Extracellularly, 
HMGB1 becomes a pro-inflammatory molecule with high affinity to several receptors 
such as RAGE and TLRs [240,241]. Therefore, released HMGB1 may serve as a 
signal from necrotic testicular cells to neighboring cells for inflammation induction.  
During infection pathogens adopt various strategies to suppress host immune 
responses thus facilitating survival [242]. In light of this, programmed necrosis may 
serve as an alternative backup mechanism to eliminate invading pathogens as well as 
damaged testicular cells when caspase-dependent apoptosis is repressed during UPEC 
infection. My findings describe a series of biochemical events and morphological 
features surrounding UPEC induced programmed necrosis in SC and PTC. However, 
the advantage of adopting programmed instead of unregulated necrosis in testicular 
somatic cells upon UPEC infection has yet to be elucidated. Similar to my 
observations, externalization of phosphatidylserine was found in programmed 
necrosis induced by the DNA alkylating agent N-methyl-N-nitro-N-nitrosoguanidine 
(MNNG) [148]. Importantly, it has been further proved that exposure of 
phosphatidylserine acts as a signal for phagocytic clearance of such necrotic corpse 
and thus leading to a less severe inflammatory response [148,223]. These findings 
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may provide crucial information for answering why programmed necrosis is adopted 
under certain conditions. Given the testis is considered as an immune privileged site, 
attenuated inflammatory response elicited by programmed necrosis may be a strategy 
employed for the elimination of pathogens and whilst minimizing the disruption of 
testicular functions. 
In conclusion, my PhD project characterizes the detrimental effects of UPEC 
infection on testis. Furthermore, the findings presented in this thesis delineate various 
necrotic cascades instead of caspase-dependent apoptotic pathways implicated in 
UPEC induced programmed cell death of SC and PTC (Figure 28). This thesis 
therefore provides a greater insight into the underlying molecular mechanisms by 
which testicular cells, specifically somatic cells in the seminiferous epithelium, 
respond to UPEC infection. Future studies are critical to elucidate upstream signaling 
pathways involved in the testicular cells demise following infection. Critically, the 
identification of the E. coli pore-forming toxin HlyA as a primary candidate for the 
induction of SC and PTC death may provide a better understanding of mechanisms 
employed by UPEC which exert deleterious effects on host cells. Further 
investigations are still required to evaluate if the damaging effects of UPEC can be 
attenuated by blocking the binding of HlyA to the membrane of target cells, which 
may lay the foundations for potential therapeutics in the future.  
It is also important to remember that the disturbance of spermatogenesis in 
bacterial orchitis is usually irreversible, even after antibiotic treatment which can 
effectively eliminate invading pathogens. Given the impact of UPEC infection is not 
only limited to germ cells but also influences testicular somatic cells, it is necessary 
for future studies to dissect the role of somatic cells demise in spermatogenesis 
impairment. Critically, UPEC induced SC and PTC death is found to be highly 
orchestrated forms of PCD. Future studies will need to incorporate a comprehensive 
delineation of signaling pathways controlling programmed necrosis in UPEC induced 
orchitis, which may pave the way for amelioration of current therapeutic strategy.  
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Figure 28 UPEC induced programmed necrosis in Sertoli (A) and peritubular cells 
(B).  
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5 SUMMARY  
 Infection and inflammation of the male reproductive tract are main aetiological 
factors of infertility. Inflammatory infertility is often based on loss of germ cell 
function and number. Uropathogenic E. coli (UPEC) is a relevant pathogen in 
urogenital infections. The aim of this study was to explore the pathomechanism that 
lead to germ cell loss during E. coli infection. Thus as a first step an in vivo model of 
epididymo-orchitis was established in rat by injecting a relevant strain of UPEC into 
the vas deferens in close proximity to the epididymis. Mimicking an infection 
ascending from the urinary tract, in the testis UPEC bacteria were found exclusively 
in the interstitial space 7 days post infection. Tracer experiments revealed that the 
integrity of the blood-testis and blood epididymis barrier was intact 7 days 
post-infection indicating that evasion of bacteria occurs probably intracellularly. In 
the testis, UPEC infection resulted in impairment of spermatogenesis by germ cell 
loss, damage of testicular somatic cells, a decrease in sperm numbers and a significant 
increase in TUNEL (+) cells. To investigate potential mechanism of germ cell death, 
hall mark steps of apoptosis were investigated. Activation of caspase-8 (extrinsic 
apoptotic pathway), caspase-3/-6 (intrinsic apoptotic pathway), caspase-1 (pyroptosis 
pathway) and the presence of 180 bp DNA fragments, all of which serve as indicators 
of the classical apoptotic pathway, were not observed in infected testis. Notably, 
electron microscopical examination revealed degenerative features of Sertoli cells (SC) 
in UPEC infected testis. Subsequent investigations focused on in vitro responses of 
SC and peritubular cells (PTC). Using UPEC wild type and mutant strains, it was 
shown that only α-hemolysin (+) E. coli strains were able to induce cell death of SC 
and PTC, but not strains that were lacking this pore forming virulence factor. 
Subsequent experiments revealed that the caspase-dependent apoptotic pathway was 
not involved in demise of these cells. Instead nuclear translocation of apoptosis 
inducing factor (AIF), rapid depletion of ATP, peripheral chromatin aggregation and 
condensation of nuclei was observed in UPEC treated SC. In contrast, activation of 
calpain, excessive production of reactive oxygen species (ROS), a gradual decline in 
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ATP levels and the homogenous condensation of nuclei were evident in UPEC 
induced PTC death. Furthermore, the passive release of high mobility group protein 
B1 (HMGB1), as an indication of the necrosis, was observed in SC, PTC and infected 
testis. In summary, the findings indicate that UPEC infection causes the induction of 
an organized self-destruction cascade termed programmed necrosis in the testis, 
which may ultimately be the major mechanism contributing to impairment of fertility. 
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6 ZUSAMMENFASSUNG 
Infektion und Entzündung des männlichen Reproduktionstraktes gehören zu den 
wesentlichen Ursachen männlicher Infertilität. Die eingeschränkte Fertilität beruht 
oftmals auf einem Verlust an Keimzellen. Ziel der vorliegenden Arbeit war es die 
Pathomechanismen zu untersuchen, die zum Keimzellverlust führen. Deshalb wurde 
zunächst ein in vivo Modell in der Ratte etabliert, bei dem eine aus dem Harntrakt 
aufsteigende Epididymo-Orchitis durch Inokulation von uropathogenen Escherichia 
coli in den Ductus deferens nahe dem Nebenhoden modellhaft nachempfunden wurde. 
Sieben Tage nach Infektion wurden UPEC Bakterien ausschließlich im Interstitium 
des Hodens gefunden, obwohl sowohl die Blut-Hoden-Schranks als auch die 
Blut-Nebenhoden-Schranke intakt waren, wie begleitende Tracerstudien ergeben 
haben. Darüberhinaus führte die UPEC Infektion im Hoden zu einer Beeinträchtigung 
der Spermatogenese durch Keimzellverlust ausgedrückt durch eine reduzierte Anzahl 
an Spermatozoen, einer  Schädigung der somatischen Zellen, und einer deutlich 
erhöhten Anzahl an TUNEL (+) Zellen im infizierten Hoden. Die für einen Zelltod 
durch den klassischen Apoptosesignalweg charakteristische Aktivierung  von 
Caspase-8 (extrinsischer apoptotischer  Signalweg), Caspase-3/-6 (intrinsischer 
apoptotischer Signalweg) und Caspase-1 (Pyroptosis), sowie die Bildung von ca. 180 
bp  langen DNA  Fragmenten  konnten  in  infizierten Hoden  jedoch nicht beobachtet 
werden.  Degenerative  Veränderungen  von  Sertoli  Zellen  (SC)  in  infizierten  Hoden 
wurden elektronenmikroskopisch nachgewiesen.  In vitro konnte mit Hilfe von UPEC 
Wildtyp und Mutanten gezeigt werden, dass ein Zelltod in SC und Peritubulär‐Zellen 
(PTC) abhängig von der Expression des Poren‐bildenden Virulenzfaktors α-Hämolysin 
(+) ist.  Weitere  Experimente  konnten  zeigen,  dass  der  Caspase-abhängige 
Apoptose-Signalweg nicht für den Zelltod der SC und PTC verantwortlich ist. 
Hingegen konnte in infizierten SC eine Translokation von AIF  (apoptosis  inducing 
factor)  in  den  Zellkern, eine schnelle Depletion  von  ATP, periphere 
Chromatinaggregation und nukleäre Kondensation beobachtet werden. In Gegensatz 
dazu fanden sich in UPEC infizierten PTC eine Aktivierung von Calpain, eine 
ZUSAMMENFASUNG 
‐ 104 ‐ 
 
massive Produktion von ROS  (reactive  oxygen  species), eine schrittweise 
Erniedrigung der ATP-Spiegel sowie eine homogene nukleare Kondensation  als 
charakteristische Merkmale. In SC und PTC als auch im infizierten Hoden  wurde 
eine passive Freisetzung  des High-Mobility-Group-Protein B1 (HMGB1),  einem 
Nekrosemarker,  beobachtet.  Zusammenfassend kann festgestellt werden, dass eine 
UPEC Infektion im Hoden zu einem Keimzellverlust durch einen organisierten 
Selbstzerstörungsprozess führt, der als programmierte Nekrose bezeichnet wird. 
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